Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 1 of 22 PageID #:52844

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS

IN RE: TESTOSTERONE REPLACEMENT MDL No. 2545 THERAPY PRODUCTS LIABILITY LITIGATION

This Document Relates to All Cases Master Docket Case No. 1:14-cv-01748

Honorable Matthew F. Kennelly

JOINT STATUS REPORT FOR AUGUST 24, 2017 CASE MANAGEMENT CONFERENCE

The Court directed counsel to file this joint report regarding the status of the parties’

discussions, agreements and disagreements on the proposed agenda items for the August 24, 2017,

case management conference.

I. Product Liability Cases

A. Update on AbbVie

1. Konrad Case: AbbVie Supplemental Expert Reports

PSC Position:

On August 18, 2017, AbbVie served the PSC with supplemental expert reports for two

experts in the Konrad case: William French, M.D. and Mohit Khera, M.D. The supplemental

expert reports draw exclusively on general and case-specific information that long pre-dates the

Konrad pre-trial order. The PSC has advised AbbVie that it objects to AbbVie’s untimely expert supplements, and seeks the Court’s guidance on the manner to present the issue to the Court in advance of the Konrad conference on September 13, 2017.

AbbVie Position:

This is AbbVie’s first notice of the PSC’s objection. As the Final Pretrial Conference for

Konrad, is scheduled for September 13th, AbbVie requests that the PSC provide its objections in

1 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 2 of 22 PageID #:52845

writing and allow AbbVie an opportunity to respond in advance of that hearing. AbbVie does

state that the supplemental expert reports were timely served in accordance with Federal Rule of

Civil Procedure 26(e)

2. Remaining AbbVie Bellwether Trial Dates: Parties will be prepared to discuss at the case management conference.

3. Update and Status on Besins: Following jurisdictional discovery and briefing, the Besins Defendants responded to written discovery requests in November 2016 and thereafter produced responsive documents, including from certain custodial files through April

2017. Thereafter, Besins moved for and was granted summary judgment in the Rowley bellwether case on the two claims remaining against it (manufacturing defect and design defect); Besins is not a defendant in any of the remaining AbbVie-only bellwether trial cases. The parties have met and conferred on discovery and motion practice. In addition to its follow-up on the productions to date, including the production of foreign language materials, the PSC advises that it anticipates serving supplemental discovery requests in September, and proceeding with deposition discovery from Besins this fall. Besins advises that it would like to set a date for the close of discovery and briefing schedule for dispositive motions. The parties will meet and confer about such matters, and be prepared to address the same with the Court at the October 5, 2017 CMC.

B. Update on Auxilium

1. Status of Discovery: The parties have been working collaboratively to

move the Auxilium litigation forward pursuant to and consistent with CMO 19A and CMO 31. To

date, the PSC has requested production from 66 custodial files. Auxilium has produced the

custodial documents from 64 of the requested files and Auxilium is working to produce the 2

2 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 3 of 22 PageID #:52846

custodial files that the PSC (in conjunction with Counsel for the State court Litigation against

Auxilium in the Court of Common Pleas in Philadelphia) requested on August 18, 2017.

As of August 24, 2017, Auxilium has produced 23 former or current employees for deposition. The PSC (in conjunction with Counsel for the State court Litigation against Auxilium in the Court of Common Pleas in Philadelphia) is scheduled to take the deposition of a former

GSK employee on August 24, 2017. On August 16, 2017, counsel for Auxilium and GSK informed the PSC and Counsel for the State court Litigation against Auxilium in the Court of

Common Pleas in Philadelphia that they were informed that same day that the deposition of a second former GSK employee had to be canceled because the witness has a medical condition that makes it unable for her to be deposed. On August 18, 2017, the PSC (in conjunction with Counsel for the State court Litigation against Auxilium in the Court of Common Pleas in Philadelphia) requested the depositions of one current GSK employee and one former GSK employee in order to obtain the testimony that was expected to be covered in the canceled deposition. The depositions thus far have all been cross-noticed and have been attended by counsel representing the state court plaintiffs, with their participation in the depositions pursuant to CMO 21.

2. Bellwether Process: The first Auxilium bellwether trial is set to begin on

November 6, 2017. On May 16, 2017, the Court entered CMO 53 selecting the following two cases as Auxilium Bellwether Trial Cases: Isaac Owens, et al v. Auxilium Pharmaceuticals, Inc.

(1:14-cv-05180) and Steve Holtsclaw v. Endo Pharmaceuticals, Inc., et al. (1:15-cv-03941).

Pursuant to CMO 53, the parties were ordered to submit a proposal to the Court at the next case management conference, which is this case management conference, recommending a process for selecting the sequence of the two Auxilium Bellwether Trial Cases (i.e., the order of the trial settings) after the completion of expert discovery pursuant to CMO 31, as noted below the parties

3 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 4 of 22 PageID #:52847

have different positions on this matter. The parties have exchanged expert witness disclosures and

are currently in the process of taking expert witness depositions. It is expected that all expert

depositions will be completed by the September 6, 2017 deadline, except for the deposition of

Auxilium’s regulatory expert, Dr. Marianne Mann, which is scheduled for September 11, 2017, by

agreement of the parties.

3. Sequence of Bellwether Trial Cases:

Auxilium’s Position

On May 16, 2017, the PSC and Auxilium submitted to the Court the parties’ joint proposed

CMO 53 (Order Selecting Two Auxilium Bellwether Trial Cases). The Court entered CMO 53

that same day and the CMO states:

The parties shall submit a proposal to the Court at the next case management conference recommending a process for selecting the sequence of the two Auxilium Bellwether Trial Cases (i.e., the order of the trial settings) after the completion of expert discovery pursuant to CMO 31.

Consistent with CMO 53, Auxilium proposes that if the parties are not able to agree on the

sequence of the two Auxilium Bellwether Trial Cases, the parties submit simultaneous briefs not

to exceed 5 pages on September 15, 2017 outlining their respective positions. Auxilium also

proposes that the Court endeavor to make a selection by September 22, 2017, which will give the

parties over 6 weeks to focus their efforts on preparing for the first Auxilium trial.

Completing expert discovery before proposing the sequence of the trials to the Court will

allow the parties to better represent to the Court their rationale for selecting which trial should go

first. Notably, CMO 61 requires the parties to submit on September 11, 2017, Summary judgment

motions and Daubert motions for both Auxilium-only bellwether trial cases and in CMO 63 the

Court set briefing page limits for both Auxilium-only bellwether trial cases. Consistent with CMO

31, CMO 53, CMO 61, and CMO 63, the plan all along has been for the parties to work up both

4 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 5 of 22 PageID #:52848

Auxilium-only bellwether trial cases and for the sequence of the trials to be selected after the completion of expert discovery.

PSC’s Position

The PSC believes the spirit of CMO 31 and 53 is that the cases should be proposed now.

The first Auxilium trial is scheduled to begin November 6, 2017. All expert reports have been served, and the parties are now scrambling to take expert depositions. The PSC is prepared to select which of the two cases it submits should be tried first and set forth its rationale for their proposed sequence of these two Auxilium trial cases. The PSC submits that Auxilium’s position that the parties should wait until the expert depositions are completed (which is over three weeks from now) will result in the first trial not being known to the parties until less than two months before the trial is scheduled to start. Simply put there is very little additional information that will help assess which case should be tried first versus which should be tried second that will come from expert depositions. And as noted above, in light of the very fast-approaching trial, this decision should be made as soon as practical, and the PSC submits simultaneous briefing by close of this week should be done.

It is also important to point out that the parties and the Court are faced with sequencing just two cases – one will go first (in November, 2017) and one will go second (in April, 2018). It is not an intricate sequencing process like with the seven AbbVie bellwether cases.

The PSC respectfully submits that identifying now which of the two cases will be tried in

November and which will be tried in April 2018 serves the parties and the Court in allowing for better final pre-trial preparation versus submitting “the process” after all expert depositions which is over three weeks from now.

5 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 6 of 22 PageID #:52849

As such the PSC is prepared to advocate which is more representative now and submits

that this be done via simultaneous submission either by close of business on Thursday August

24, 2017 or by 2pm on Friday, August 25, 2017, with the Court hopefully deciding the sequence

the following week. The PSC is fully prepared to discuss its position with the court at the CMC

if the Court wishes.

4. Status of Motions to Strike Affirmative Defenses in the Two Bellwether

Cases: On July 5, 2017, Plaintiffs in both Auxilium bellwether cases filed motions to strike certain affirmative defenses. By separate stipulations in both cases, the parties narrowed the affirmative defenses challenged. In light of the revised stipulation in Holtsclaw, Mr. Holtsclaw now challenges two affirmative defense: No. 7 and No. 16. In light of the stipulation in Owens, Mr.

Owens now challenges two affirmative defenses: No. 4 and No. 22. The motions are fully briefed.

5. Status of Auxilium State Court Litigation: Pursuant to CMO 31 and

CMO 61, the PSC and Counsel for the State Court Litigation against Auxilium in the Court of

Common Pleas in Philadelphia are working in coordination with the understanding that the first of the Auxilium MDL bellwether cases will be tried in advance of the cases pending before Judge

Rau, Judge Younge, and Judge Cohen in that Court.

C. Update on Eli Lilly & Co.

1. Status of Pending Discovery

The PSC continues to take depositions of Lilly employees. While fact discovery closed as

to depositions of current and former employees of Lilly on August 18, 2017, the parties have

reached an agreement to complete the deposition of former employee Nancy Ostrowski within a

reasonable time beyond this deadline. The necessity to take her deposition after August 18, 2017

6 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 7 of 22 PageID #:52850

arose primarily due to the deponent’s refusal to appear voluntarily for a deposition. All other Lilly

fact discovery depositions have been completed.

Additionally, Plaintiffs intend to take the deposition of Allison Kramer, an employee of

the third party Grey Global. Discussions are ongoing as to the date of her deposition. However,

the PSC anticipates the deposition may need to occur after the third party discovery deadline of

September 15, 2017 given that the witness is presently on temporary leave from her employer.

The PSC will endeavor to ensure the deposition occurs as soon as possible and have notified Lilly

of the reason for delay in completing her deposition.

2. Status of Bellwether Process

Fact discovery has been completed as to the Lilly bellwether cases. The PSC has served

its expert reports as to all of its experts except for one. The parties have agreed to a brief extension

until August 23, 2017 to serve the expert report of Dr. Peggy Pence. A similar extension has been

made available to Lilly if necessary. However, these extensions will not otherwise impact the

deadlines in existence for the bellwether cases.

Per the Court’s directive, the parties have begun discussing revisions to the briefing

schedule for motions for summary judgment or for partial summary judgment and/or motions

seeking to challenge expert testimony pursuant to Daubert as set forth in CMO 19-C. The parties

will update the Court on those discussions at the Status Conference.

D. Update on Endo

1. Status of Discovery: To date, the PSC has requested production from 40 custodial files and Endo has produced custodial files for 35 of the requested custodians. It appears that the

remaining 5 requested custodians were never employed by or worked for Endo and thus have no

custodial files. At this time, there are no outstanding requests for Endo custodial files.

7 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 8 of 22 PageID #:52851

As of August 24, 2017, Endo has produced 7 former or current employees for deposition.

The depositions thus far have been cross-noticed and have been attended by counsel representing

the state court plaintiffs, with their participation in the depositions pursuant to CMO 21.

Pursuant to CMO 33, non-expert fact discovery against Endo was scheduled to be

completed by July 14, 2017, and the first Endo trial is set for September 10, 2018. As the parties

reported in the May 2017 Status Report, the parties agree that they need to extend the non-expert fact discovery and that doing so will not impact the trial date. The parties are meeting and

conferring on a new non-expert fact discovery cutoff date and they are optimistic that they will be able to submit a joint proposed CMO to the Court.

2. Bellwether Process: Pursuant to CMO 33, on July 14, 2017, the parties selected a pool of cases where Endo is the only defendant and the only testosterone product used was Fortesta.

After eliminating mixed-use cases, the pool consists of 32 cases. Auxilium served abbreviated

Defense Fact Sheets for the 32 cases on August 15, 2017 and on August 25, 2017 each party will identify their 3 bellwether cases.

E. Update on Actavis

1. Bellwether Selection Process:

The Parties selected six Actavis-only, Androderm-only bellwether discovery cases per the

CMO 37 protocol. Those selections were based upon plaintiff’s sworn fact sheets. However,

Actavis Defendants collection of medical records in the William Morgan v. Actavis Pharma, Inc., et al. case selected by Actavis Defendants revealed that plaintiff used several other TRT products along with Androderm. The parties agreed that the case must be excluded as mixed-use, and since that time Actavis Defendants have worked to identify additional eligible cases for replacement

(excluding those with mixed-use revealed in medical records), provide the list of those cases to

8 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 9 of 22 PageID #:52852

plaintiff’s counsel, and propose a protocol for choosing one replacement case. The PSC accepted

Actavis Defendants proposed protocol on August 18, 2017, and the parties anticipate selection of

a replacement case by September 1, 2017.

2. Defense Fact Sheet:

The Parties have met and conferred about the form and scope of a Defense Fact Sheet

(“DFS”) that Actavis Defendants have agreed to voluntarily provide in the bellwether discovery

cases. As part of that DFS, plaintiffs have requested that Actavis Defendants provide information

regarding contacts with the prescribing physicians for the bellwether discovery plaintiffs that

occurred in the form of either Dear Doctor letters, Professional Medical Information Requests,

and/or visits from Actavis sales representatives regarding Androderm. Additionally, plaintiffs

have requested that Actavis Defendants produce call notes for any visits from Actavis sales representatives for Androderm and any data regarding product samples, leave behinds, or literature provided to those prescribing physicians during those visits.

Relevant Time Period:

Plaintiffs’ Position

The Parties have met and conferred about the form and scope of the DFS Actavis

Defendants will provide on the bellwether cases. Actavis Defendants requested that the relevant

time period be limited to January 1, 2010 through the time of injury.

The PSC disagrees. The Actavis Defendants should produce responsive information on the

bellwether cases exactly as the other defendants did: from the time of FDA approval through the

time of injury. FDA granted Actavis Defendants approval to market Androderm on September 29,

1995. Eliminating Actavis Defendants’ prescriber contact information for the first fifteen years it

9 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 10 of 22 PageID #:52853

marketed the product would potentially eliminate relevant, probative evidence and be a disservice

to the bellwether process.

Actavis Defendants’ Position:

Actavis Defendants are agreeable to providing a DFS in each bellwether discovery case

that provides the information requested regarding contacts with plaintiff’s prescribing physicians,

if any. However, Actavis Defendants have explained to plaintiffs’ counsel that the marketing and promotion of Androderm was limited. Given that limited marketing and promotion of Androderm, it is more likely the case that the prescribing physicians in the bellwether cases were not called on by any Actavis employee regarding Androderm. Indeed, Actavis Defendants preliminary review of accessible data after January 1, 2010, to the date of alleged injury in each bellwether case indicates the prescribing physicians at issue were not called on for Androderm. Actavis

Defendants have proposed providing the information requested by plaintiffs for the time period of

January 1, 2010 through the date of injury at issue in each of the bellwether cases, as the information requested for that period is reasonably accessible to Actavis Defendants. Based on investigation to date, the Actavis Defendants have not been able to confirm that information of the type requested that pre-dates January 1, 2010, exists. If it does, the information is not easily accessible to Actavis Defendants. Moreover, in all of the bellwether cases selected to date, plaintiffs allege injury occurred after January 1, 2010, and in each of the cases, with the exception of one, plaintiff was not prescribed and did not use Androderm prior to January 1, 2010. As such,

Actavis Defendants’ believe their proposal provides the information requested during the relevant time period for each bellwether discovery plaintiff. Plaintiffs have not agreed to limit the relevant time period in the DFS to January 1, 2010 to date of injury. Actavis Defendants continue to investigate the existence and availability of the information requested that pre-dates January 1,

10 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 11 of 22 PageID #:52854

2010, and will provide plaintiffs’ counsel with an update on whether such information exists and, if so, the degree to which it is accessible.

IMS Data:

The Parties have also met and conferred about production of IMS (prescribing habit) data regarding the prescribing physicians in the bellwether cases, if any. The PSC believes that Actavis

Defendants should produce this information as the other defendants did. (That is, to the extent it is held in a sales call database or the like, it must be produced). Actavis Defendants are agreeable to producing IMS data, to the extent it exists, for any of the prescribing physicians it called upon for Androderm in the bellwether discovery cases. However, Actavis Defendants question the relevance of IMS data regarding physicians it did not visit for Androderm. Negotiations regarding the scope and timing of production of IMS data, to the extent it exists, are ongoing.

Custodial File Production of the Sales Representatives Identified in the DFSs:

Actavis Defendants and the PSC agree that Actavis Defendants will produce sales representative custodial files for sales representatives who called on any of the prescribing physicians for Androderm in the bellwether discovery cases to the extent such custodial files exist.

Actavis Defendants will use the same search protocol on those files, if any, as used on other custodial files collected and produced in this litigation. Given the limited marketing and promotion of Androderm, and that preliminary review of accessible data after January 1, 2010, to the date of alleged injury in each bellwether case indicates the prescribing physicians at issue were not called on regarding Androderm, Actavis Defendants anticipate that it is likely there are few, if any, custodial files to produce. Actavis Defendants and the PSC agree that if there was no sales visits for Androderm for a particular prescriber, then there will be no associated sales representative’s custodial file for production.

11 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 12 of 22 PageID #:52855

Timing of the DFS, Sales Rep Custodial Files, and IMS Data:

Plaintiffs’ Position:

Because the Court has set December 1, 2017 as the discovery cut in the Actavis bellwether cases, the DFS must be completed and is ripe for resolution.

On July 12, 2017, the PSC asked Actavis Defendants to stipulate to production of all sales custodial files by September 15, 2017. Actavis Defendants provided a proposed DFS on July 31.

On an August 1 call, the PSC inquired about the limiting date of January 1, 2010. However, lead counsel was not available to discuss that issue until the following week so the PSC sent an email on August 1 outlining open issues including questioning the limiting date of January 1, 2010. On an August 9 call, Actavis Defendants indicated that if the PSC would limit the relevant time to no earlier than 2010, Actavis Defendants could respond relatively quickly. On August 11, 2017, the

PSC informed Actavis Defendants that the 2010 limitation would be unacceptable and asked

Actavis Defendants to complete production of the DFSs and sales representative custodial files by

September 15, but suggested giving Actavis Defendants until October 15 to complete the IMS data production.

Again because of the December 1, 2017 discovery deadline, the PSC believes Actavis

Defendants must produce the DFSs, the related call notes, and the custodial files by September 15 and the IMS data by October 15.

Actavis Defendants’ Position:

Plaintiffs first provided counsel for Actavis Defendants with a sample of the DFS agreed to with other defendants on July 12, 2017. Counsel for Actavis Defendants then drafted a proposed

DFS specific to the Actavis-only cases and nearly identical to the sample DFS provided by plaintiffs. Actavis Defendants provided that approved draft to plaintiffs’ counsel on July 31, 2017,

12 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 13 of 22 PageID #:52856

and advised plaintiffs’ counsel that the draft DFS was agreeable. Actavis Defendants proposed

DFS provided the same information as provided for in the sample DFS shared by plaintiffs’ counsel. The only significant substantive revision was the relevant time period for production of the information requested. As noted, plaintiffs’ counsel has rejected Actavis Defendants proposed time period, and seeks information from 1995 through the date of injury. The broad scope of this request requires Actavis Defendants to conduct additional investigation regarding the existence and reasonable availability of the information requested that pre-dates January 1, 2010. Once that issue is determined, the time frame by which the information requested can be provided can be determined. In any event, given the limited nature of the marketing and promotion of Androderm,

Actavis Defendants anticipate that the information produced, if any, will not be voluminous.

2. Custodial File Production (other than sales representatives identified on the six DFSs) and Non-Custodial File Production:

Actavis Defendants have completed production of all requested custodial files. Actavis

Defendants are working to finalize transmission of certificates of completeness for each custodial files produced. Actavis Defendants have substantially completed production of responsive non- custodial files. Additional share files are being reviewed for any potentially responsive non- custodial documents.

3. Privilege Log:

After meeting and conferring with the PSC, Actavis Defendants voluntarily agreed to prepare a supplemental privilege log that includes the subject matter of any withheld documents so that the PSC will be able to raise challenges, if appropriate. However, Actavis Defendants have not provided the supplemental privilege log to the PSC yet. Actavis Defendants anticipate it will be completed by August 31, 2017.

4. Depositions:

13 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 14 of 22 PageID #:52857

Plaintiffs have requested dates for the depositions of five former employees of Actavis

Defendants. Actavis Defendants have confirmed that three of those former employees are

agreeable to voluntarily appearing for deposition in the TRT MDL, and the deposition of one of

those former employees is scheduled for September 14, 2017. Actavis Defendants have requested

plaintiffs’ counsel provide dates they are available to depose the other two former employees so

those individuals can schedule an available date on their calendar that also work for their current

employers. Actavis Defendants are working to determine the availability of the two remaining

former employees for a deposition.

Actavis Defendants have requested dates for the deposition of plaintiff in the Jerome

Danzey case on July 10, 2017. After receiving no response, Actavis Defendants noticed plaintiff

Jerome Danzey’s deposition for September 7, 2017. Plaintiff’s counsel responded once the Notice was issue on August 15, 2017, and he has advised he is unavailable for Mr. Danzey’s deposition on that date. Actavis Defendants are waiting for alternative dates from plaintiff’s counsel.

F. “Mixed Use” Cases: The parties submitted their respective positions on this issue simultaneously on July 13, 2017.

G. Dismissal Lists: The parties have attached CMO 26 and 9 Dismissal Lists as Exhibits

A and B respectively and will also provide the lists to the Court in Excel format by email. There are no outstanding objections from the previous or current lists that would warrant counsel presenting their disputes to the Court.

II. Third Party Payor Case - Allied Services Lawsuit

Defendants’ Position

As the Court may recall, while motion-to-dismiss briefing in the Medical Mutual of Ohio

(“MMO”) lawsuit was underway, another third-party payor, Allied Services Division Welfare

Fund (“Allied Services”), filed a copycat complaint in this MDL, seeking to certify the very same

14 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 15 of 22 PageID #:52858

class of third-party payors (“TPPs”) under the very same RICO theory. See Allied Servs. Div.

Welfare Fund v. AbbVie Inc., et al., No. 15-cv-9525 (N.D. Ill.). The Allied Services complaint was

borrowed almost verbatim from MMO’s original complaint in this action, which the Court

subsequently dismissed. However, for unknown reasons, the Allied Services complaint names only

the AbbVie and Auxilium groups of entities as defendants and does not include Eli Lilly or

Actavis.

In November 2015, the Court stayed the Allied Services action pending resolution of the

motions to dismiss in MMO. See No. 15-9525, ECF No. 5 (N.D. Ill. Nov. 13, 2015). Thereafter, the Court dismissed MMO’s original complaint; MMO repled; and the Court deemed MMO’s substantially revised Third Amended Complaint sufficient to state a claim. Since that time, Allied

Services has not taken any steps to lift the stay, amend its complaint to conform with the Court’s

rulings in MMO, or otherwise pursue its claims.

Consequently, on June 15, 2017, counsel for AbbVie and Auxilium approached Allied

Services and asked it to voluntarily dismiss. See Exhibit C (6/15/2017 Letter). As Defendants

explained, the Court’s rulings in MMO made it clear that the Allied Services complaint failed to

state a claim. Defendants also observed that, in another recent pharmaceutical RICO action, Allied

Services had voluntarily dismissed its claims years into the proceedings—after an appeal to the

Third Circuit and a fully-briefed petition for certiorari—when it discovered that its historical

prescription-claims data had not been preserved. Allied Services is currently faced with a

sanctions motion in that action for allegedly filing and litigating its RICO claims without

conducting the investigation that Rule 11 requires. See Allied Servs. Div. Welfare Fund v.

GlaxoSmithKline, LLC, et al., No. 2:09-cv-00730, ECF No. 97 (E.D. Pa. Nov. 8, 2016). That issue

would seem dispositive here as well.

15 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 16 of 22 PageID #:52859

On July 17, 2017, counsel for Allied Services responded to AbbVie and Auxilium that it

still intended to pursue its claims. Since that time, however, Allied Services has not taken any

steps to do so. Accordingly, AbbVie and Auxilium respectfully ask the Court to order Allied

Services to show cause by a date certain why its complaint should not be dismissed for failure to

state a claim and/or for failure to prosecute. In the alternative, AbbVie and Auxilium intend to

bring a motion to dismiss the Allied Services complaint.

Plaintiff/Allied Position:

Plaintiff Allied Services Division Welfare Fund (hereafter “ASD” or “Allied”) filed its

complaint on October 26, 2015. See Allied Servs. Div. Welfare Fund v. AbbVie Inc., et al., No. 15-

cv-9525 (N.D. Ill.). (Dkt. 1). That case was stayed on November 13, 2015 pending the outcome

of the Motion to Dismiss in the Medical Mutual of Ohio case (No. 15-cv-9525 (N.D. Ill.). (Dkt.

5). The Motion to Dismiss in MMO was granted in part and denied in part on August 2, 2016 (

14-cv-08857, Dkt. 170) and thereafter defendant Actavis moved for reconsideration and alternatively certification for appeal under 28 USC 1292(b), both of which were denied by the

Court on September 8, 2018. See 14-cv-08857, Dkt. 182.

On June 15, 2017, counsel for AbbVie and Auxilium demanded that ASD voluntarily dismiss its case, suggesting that in their opinion ASD could not cure the defects in its complaint, noting that motion for sanctions against ASD in an unrelated case (Allied Servs. Div. Welfare Fund v. GlaxoSmithKline, LLC, et al., No. 2:09-cv-00730), and arguing that ASD’s complaint is redundant because ASD is already a member of a putative class. See Exhibit C (6/15/2017

Letter).

16 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 17 of 22 PageID #:52860

Given the Court’s ruling on the Motions to Dismiss in the MMO case ASD will amend its

Complaint accordingly. With regard to the allegations by AbbVie that the issue in the Allied v

GSK, et al. matter would be dispositive in this case as well, AbbVie is mistaken. In Allied v GSK

Sanctions were sought against ASD for allegedly failing to perform a pre-suit investigation and

filing its Complaint without the requisite data to back up its allegations. A pre-suit investigation

was in fact made and counsel confirmed Allied’s purchases of Avandia during the class period.

Allied provided GSK its claims data for 2008 forward, and then in late 2016 counsel located the previously obtained purchase data from 1999 forward and provided same to GSK. The motion for sanctions was fully briefed and argued. The Court has not yet ruled. Regardless of the issues in the Avandia case, here, Allied’s complaint was filed in reliance of purchase data from AtlanticRx,

Allied’s pharmacy benefits manager from 2009-2012. None of the alleged issues raised in the

Avandia case are present here.

Finally, the allegation that ASD should dismiss because it is already a putative class member is without merit. It is not uncommon to have more than one class representative for Third

Party Payor classes. See for example In re: Generic Pharmaceutical Antitrust Litigation, 2:16- md-02724, E.D. Pa which has several TPP class representatives; In Re Actos (Pioglitazone)

Products Liability Litigation; MDL NO. 6:11-md-2299, W.D. La. which also has several TPP class representatives including Allied and Blue Cross Blue Shield of Louisiana. Allied is a small Health and Welfare Fund providing benefits for union members mostly in the transportation industry. Its purchases and plans may be different from other TPP’s already named. There is no reason to dismiss ASD simply because it is already a putative class member.

17 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 18 of 22 PageID #:52861

ASD believes that its complaint can be amended to comply with the orders already entered by this Court, and will do so, as stated in its letter to AbbVie counsel on July 17, 2017. See Ex.

D.

Dated: August 22, 2017 Respectfully submitted,

/s/ Trent B. Miracle Trent B. Miracle SIMMONS HANLY CONROY One Court Street Alton, IL 62002 Telephone: (618) 259-2222 Facsimile: (618) 259-2251 [email protected]

Plaintiffs’ Co-Lead Counsel

Ronald Johnson, Jr. SCHACHTER, HENDY & JOHNSON PSC 909 Wrights Summit Parkway, Suite 210 Ft. Wright, KY 41011 Phone: (859) 578-4444 Fax: (859) 578-4440 [email protected]

Plaintiffs’ Co-Lead Counsel

Christopher A. Seeger SEEGER WEISS LLP 77 Water Street New York, NY 10005 Phone: (212) 584-0700 Fax: (212) 584-0799 [email protected]

Plaintiffs’ Co-Lead Counsel

David M. Bernick Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, NY 10019-6064 Phone: (212) 373-3405 Fax: (212) 492-0405 [email protected]

18 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 19 of 22 PageID #:52862

Attorney for AbbVie, Inc.

Hope S. Freiwald DECHERT LLP Cira Center 2929 Arch Street Philadelphia, PA 19104 Tel: (215) 994-2514 Fax: (215) 994-2222 [email protected]

Attorney for AbbVie Inc. and Abbott Laboratories

David E. Stanley Janet H. Kwuon REED SMITH LLP 355 S. Grand Avenue, Suite 2900 Los Angeles, CA 90071 Tel: (213) 457-8000 [email protected] [email protected]

Attorneys for Eli Lilly and Company and Lilly USA LLC

Andrew K. Solow ARNOLD & PORTER KAYE SCHOLER LLP 250 West 55th Street New York, NY 10019 Tel: (212) 836-7740 Fax: (212) 836-6776 [email protected]

Pamela J. Yates ARNOLD & PORTER KAYE SCHOLER LLP 1999 Avenue of the Stars, Suite 1700 Los Angeles, CA 90067 Tel: (310) 788-1278 Fax: (310) 788-1200 [email protected]

Attorneys for Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, Inc.

Loren H. Brown

19 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 20 of 22 PageID #:52863

Cara D. Edwards DLA PIPER LLP (US) 1251 Avenue of the Americas New York, NY 10020 Phone: (212) 335-4500 Fax: (212) 335-4501 [email protected] [email protected]

Matthew A. Holian Jessica C. Wilson DLA PIPER LLP (US) 33 Arch Street, 26th Floor Boston, MA 02110 Phone: (617) 406-6000 Fax: (617) 406-6001 Email: [email protected] Email: [email protected]

Attorneys for Pfizer Inc. and Pharmacia & Upjohn Company LLC

Joseph P. Thomas Jeffrey F. Peck K.C. Green Jeffrey D. Geoppinger ULMER & BERNE LLP 600 Vine Street, Suite 2800 Cincinnati, OH 45202 Phone: (513) 698-5000 Fax: (513) 698-5001 E-mail: [email protected]

Attorneys for Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Inc.

20 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 21 of 22 PageID #:52864

James W. Matthews (pro hac vice) Katy E. Koski (pro hac vice) Jason L. Drori (pro hac vice) FOLEY & LARDNER LLP 111 Huntington Ave. Boston, MA 02199 Tel: (617) 342 – 4000 Fax: (617) 342 – 4001 [email protected] [email protected] [email protected]

Jonathan W. Garlough FOLEY & LARDNER LLP 321 North Clark Street, Suite 2800 Chicago, IL 60654-5313 Tel: (312) 832 – 4500 Fax: (312) 832 – 4700 [email protected]

Attorneys for Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Inc.

William F. Cavanaugh, Jr. (pro hac vice) Jonah Moses Knobler (pro hac vice) PATTERSON BELKNAP WEBB & TYLER 1133 Avenue of the Americas New York, NY 10036-6710 Tel: (212) 336-2000 Fax: (212) 336-2222 [email protected] [email protected]

Attorneys for AbbVie Inc. and Abbott Laboratories

21 Case: 1:14-cv-01748 Document #: 2105 Filed: 08/22/17 Page 22 of 22 PageID #:52865

CERTIFICATE OF SERVICE

I hereby certify that on August 22, 2017, the foregoing document was filed via the Court’s

CM/ECF system, which will automatically serve and send email notification of such filing to all registered attorneys of record.

/s/ Brendan A. Smith

Brendan A. Smith SIMMONS HANLY CONROY One Court Street Alton, IL 62002 Telephone: (618) 259-2222 Facsimile: (618) 259-2251 [email protected]

22 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 1 of 36 PageID #:52866

Exhibit A Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 2 of 36 PageID #:52867

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Kenneth & Lisa Deemer v 1:15‐cv‐06921 ALYSTOCK, WITKIN, KREIS & OVERHOLTZ Joint Motion to Drop Dismissed: Acrux Commercial Pty Ltd.; Acrux DDS Pty Ltd.; Eli Lilly & Co.; Lilly USA, LLC; Without No No AbbVie Inc., et al. Stephen N. Echsner Party Defendants Actavis Laboratories UT, Inc.; Actavis Pharma, Inc.; Actavis, Inc.; and Anda, Inc. Prejudice objection objection 17 East Main St., Suite 200 Pursuant to F.R.C.P. 21 Remaining: AbbVie Inc, Abbott Laboratories, AbbVie Products LLC Pensacola, FL 32502 filed 2/14/17 and Previously dismissed: Actavis plc and Watson Laboratories, Inc. (NV) Phone: (850) 202‐1010 2/15/17 Email: [email protected]

Robert Pitts v. Eli Lilly and 1:16‐cv‐6080 BARON & BUDD P.C. Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux Without No No Company; Lilly USA, LLC; Matthew Haynie. Dismissal without DDS Pty Ltd. Prejudice objection objection Acrux Commercial Pty 3102 Oak Lawn Avenue Prejudice on 10/3/16 Remaining: Endo Pharmaceuticals, Inc.; Auxilium Pharmaceuticals, Inc.; Ltd; Acrux DDS Pty Ltd; Suite 1100 GlaxoSmithKline, LLC Endo Pharmaceuticals, Dallas, TX 75219 Inc.; Auxilium (214)521‐3605 Pharmaceuticals, Inc.; [email protected] GlaxoSmithKline, LLC

Patrick M. Canal v. AbbVie 1:15‐cv‐06831 BEASLEY, ALLEN, CROW, METHVIN, Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No Inc., et al. PORTIS, & MILES, P.C. Dismissal filed 7/24/17 Inc. Prejudice objection objection Matthew Patrick Teague Remaining: AbbVie Inc; Abbott Laboratories; Abbvie Products LLC; Unimed P.O. Box 4160 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. Montgomery, AL 36103‐4160 Previously Dismissed: Solvay, S.A.; Actavis plc; Watson Laboratories, Inc., a Nevada Phone: (334) 269‐2343 corporation Email: [email protected]

Richard Marinos v. Endo 1:16‐cv‐09107 Burke Harvey, LLC Notice of Voluntary Dismissed: Endo International, plc, and DPT Laboratories, Ltd. Without No No International, plc Inc., et Amanda H. Schafner dismissal filed for Remaining: Endo Pharmaceuticals, Inc. and Auxilium Pharmaceuticals, Inc. Prejudice objection objection al. William T. Harvey Endo International, plc 3535 Grandview Parkway, Suite 100 and DPT laboratories, Birmingham, AL 35243 Ltd. Filed separately Phone: (205) 930‐9091 on 10/4/2016 Fax: (205) 930‐9054 Email: [email protected] tharvey@burkeharvey,com

Page 1 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 3 of 36 PageID #:52868

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Walter Ricks v. Actavis, 1:16‐cv‐06106 BEASLEY, ALLEN, CROW, METHVIN, Stipulation of Entire Action Without No No Inc., et al. PORTIS, & MILES, P.C. Dismissal filed 7/24/17 Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Prejudice objection objection Matthew Patrick Teague Inc. P.O. Box 4160 Montgomery, AL 36103‐4160 Phone: (334) 269‐2343 Email: [email protected]

Roger Wilcox, et al. v. 1:15‐cv‐08849 BURG SIMPSON ELDREDGE HERSCH Stipulation of Entire Action Without No No Actavis, Inc., et al. JARDINE PC Dismissal filed 5/5/17 Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Prejudice objection objection Meghan Quinlivan Inc. 40 Inverness Drive East Previously dismissed: Actavis plc and Watson Laboratories, Inc. Englewood, CO 80112 Phone: (303) 792‐5595 Email: [email protected]

Stuart Gross v. AbbVie 1:15‐cv‐2092 CASEY GERRY SCHENK FRANCAVILLA Amended complaint Dismissed: Watson Laboratories, Inc. Without No No Inc., et al. BLATT & PENFIELD, LLP filed 3/29/17 Remaining: AbbVie, Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection Wendy M. Behan Pharmaceuticals, LLC, Besins Healthcare Inc., Besins Healthcare, S.A., Actavis, Inc., Actavis 110 Laurel Street Pharma, Inc., Actavis Laboratories UT, Inc. and Anda, Inc. San Diego, CA 92101 Phone: (619) 238‐1811 Email: [email protected]

George A. Denton v. 1:15‐cv‐03663 COHEN & MALAD, LLP Stipulation of Dismissed: Pfizer, Inc. and Pharmacia & UpJohn Company With No No Pfizer, Inc., et al. Edward B. Mulligan, V Dismissal filed Remaining: Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., Anda, Inc. Prejudice objection objection One Indiana Square, Suite 1400 12/23/2016 Previously Dismissed: Actavis plc and Watson Laboratories, Inc. Indianapolis, IN 46204 (317) 636‐6481 [email protected]

Page 2 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 4 of 36 PageID #:52869

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Alanis, et al. v. AbbVie, 1:15‐cv‐07844 COHEN & MALAD, LLP Stipulation of Dismissed: Pfizer, Inc. and Pharmacia & UpJohn Company With No No Inc., et al. Edward B. Mulligan, V Dismissal filed Remaining: AbbVie, Inc., Abbott Laboratories, AbbVie Products, LLC, Unimed Prejudice objection objection One Indiana Square, Suite 1400 01/09/2017 Pharmaceuticals, LLC, Besins Healthcare, Inc., Besins Healthcare, S.A., Actavis, Inc., Indianapolis, IN 46204 Actavis Pharma, Inc., Actavis Laboratories UT, Inc., Anda, Inc. (317) 636‐6481 Previously Dismissed: Actavis plc, Watson Laboratories, Inc., Solvay, S.A. [email protected] Augustin Del Hoyo, et al. 1:16‐02768 COHEN & MALAD, LLP Stipulation of Dismissed: Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., Anda, Inc. Without No No v. AbbVie Inc., et al. Edward B. Mulligan V Voluntary Dismissal Remaining: AbbVie, Inc., Abbott Laboratories, AbbVie Products, LLC, Unimed Prejudice objection objection One Indiana Square filed on 9/29/16 Pharmaceuticals, LLC, Besins Healthcare, Inc., Besins Healthcare, S.A. Suite 1400 Previously Dismissed: Solvay, S.A. Indianapolis, IN 46204 Phone: (850)435‐7000 Email: [email protected]

Cameron North, et al. v. 1:15‐cv‐08212 COHEN & MALAD, LLP Stipulation of Dismissed: Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., Anda, Inc. Without No No AbbVie Inc., et al. Edward B. Mulligan V Voluntary Dismissal Remaining: AbbVie, Inc., Abbott Laboratories, AbbVie Products, LLC, Unimed prejudice objection objection One Indiana Square filed on 9/29/16 Pharmaceuticals, LLC, Besins Healthcare, Inc., Besins Healthcare, S.A. Suite 1400 Previously Dismissed: Actavis plc, Watson Laboratories, Inc., Solvay, S.A. Indianapolis, IN 46204 Phone: (850)435‐7000 Email: [email protected]

George Cooksey, et al. 1:15‐cv‐06953 COHEN & MALAD, LLP Stipulation of Dismissed: Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., Anda, Inc. Without No No Edward B. Mulligan V Dismissal filed Remaining: AbbVie, Inc., Abbott Laboratories, AbbVie Products, LLC, Unimed Prejudice objection objection One Indiana Square 11/17/16 Pharmaceuticals, LLC, Besins Healthcare, Inc., Besins Healthcare, S.A. Suite 1400 Previously Dismissed: Actavis plc, Watson Laboratories, Inc., Solvay, S.A. Indianapolis, IN 46204 Phone: (850)435‐7000 Email: [email protected]

Page 3 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 5 of 36 PageID #:52870

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Adams, Robert R. v. 1:15‐cv‐09962 Discepolo LLP Voluntary/Stipulated Dismissed: AbbVie Inc. and Abbott Laboratories Without No No AbbVie Inc. et al. A. Donald C. Discepolo Dismissal filed Remaining: Auxilium Pharmaceuticals Inc. Prejudice objection objection 8850 Columbia 100 Parkways 1/9/2017 Suite 310 Columbia, MD 21044 Telephone: 410‐296‐0780 [email protected] Timothy W. Peters v. 1:15‐cv‐04761 DOMENGEAUX WRIGHT ROY EDWARDS Stipulation for Dismissed: Actavis Pharma, Inc.; Watson Laboratories, Inc.; and Anda, Inc. Without No No Auxilium Elwood C. Stevens, Jr. Voluntary Dismissal Remaining: Auxilium Pharmaceuticals, Inc.; and GlaxoSmithKline, LLC Prejudice objection objection Pharmaceuticals, Inc., et 556 Jefferson Street, Suite 500 filed 10/6/16 al. Lafayette, LA 70502 Phone: (337) 593‐4179 Email: [email protected]

Karen Logan, et al. v. 1:16‐cv‐03487 Douglas & London Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No Pfizer, Inc., Pharmacia & Michael A. London Dismissal filed Remaining: Endo Pharmaceuticals Inc. Prejudice objection objection Upjohn Company Inc. and 59 Maiden Lane 6th Floor 1/17/2017 Endo Pharmaceuticals New York, NY 10038 212‐931‐9979 [email protected] Manear, James v. AbbVie 1:16‐cv‐01781 EISENBERG, ROTHWEILER, WINKLER, Voluntary/Stipulated Entire Action Without No No Inc. et al. EISENBERG & JECK, PC Dismissal filed Dismissed: AbbVie Inc.; Abbott Laboratories; AbbVie Products, LLC; Unimed Prejudice Objection objection Kenneth M. Rothweiler 9/19/2016 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Endo Rita Assetto‐Sherry Pharmaceuticals Inc.; Auxilium Pharmaceuticals, LLC (f/k/a Auxilium Pharmaceuticals, 1634 Spruce Street Pfizer and Upjohn Inc.); GlaxoSmithKline LLC; Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Philadelphia, PA 19103 Dismissed Pursuant to Inc.; and Anda, Inc (215) 546‐6636 CM0 19B Previously dismissed: Pfizer Inc. and Pharmacia and Upjohn Company, Solvay SA, Eli Lilly [email protected] and Company, Lilly USA, LLC, Acrux Commercial Pty Ltd., Acrux DDS Pty Ltd. [email protected]

Page 4 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 6 of 36 PageID #:52871

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Rodgers v. AbbVie Inc., et 1:16‐cv‐01786 EISENBERG, ROTHWEILER, WINKLER, Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No al. EISENBERG & JECK, PC Dismissal filed Remaining: Endo Pharmaceuticals Inc. Prejudice objection objection Kenneth M. Rothweiler 01/06/2017 Previously dismissed: AbbVie Inc.; Abbott Laboratories; AbbVie Products, LLC; Unimed Rita Assetto‐Sherry Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A., Solvay SA, Eli Lilly 1634 Spruce Street and Company, Lilly USA LLC, ACrux Commercial Pty Ltd, Acrux DDS Pty Ltd, Auxilium Philadelphia, PA 19103 Pharmaceuticals Inc., GlaxoSmithKline LLC, Actavis Inc., Actavis Pharma Inc., Actavis (215) 546‐6636 Laboratories UT Inc., Anda Inc. [email protected] [email protected] Pollock v. AbbVie Inc., et 1:16‐cv‐01760 EISENBERG, ROTHWEILER, WINKLER, Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No al. EISENBERG & JECK, PC Dismissal filed Remaining: Endo Pharmaceuticals Inc. Prejudice objection objection Kenneth M. Rothweiler 01/06/2017 Previously dismissed: AbbVie Inc.; Abbott Laboratories; AbbVie Products, LLC; Unimed Rita Assetto‐Sherry Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Auxilium 1634 Spruce Street Pharmaceuticals, LLC (f/k/a Auxilium Pharmaceuticals, Inc.); GlaxoSmithKline LLC; Philadelphia, PA 19103 Actavis, Inc.; Actavis Pharma, Inc.; Atavis Laboratories UT, Inc.; and Anda, Inc. (215) 546‐6636 [email protected] [email protected] William Bumgardner, et 1:16‐cv‐06312 EISENBERG, ROTHWEILER, WINKLER, Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No al. v. AbbVie Inc., et al. EISENBERG & JECK, PC Dismissal filed 3/7/17 Inc. Prejudice objection objection Kenneth M. Rothweiler Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Rita Assetto‐Sherry Pharmaceuticals LLC, Besins Healthcare SA, Besins Healthcare Inc. 1634 Spruce Street Previously dismissed: Solvay SA Philadelphia, PA 19103 (215) 546‐6636 [email protected] [email protected] Kenneth Clark v. AbbVie 1:15‐cv‐07813 ENVIRONMENTAL LITIGATION GROUP, Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No Inc., et al. P.C. Dismissal filed Remaining: Abbvie, Inc., Abbott Laboratories, Abbvie Products, LLC Prejudice objection objection Gary A. Anderson 12/16/2016 2160 Highland Ave. South, Suite 200 Birmingham, AL 35205 (205) 328‐9200 [email protected]

Page 5 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 7 of 36 PageID #:52872

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Gary Young v. AbbVie 1:15‐cv‐07830 ENVIRONMENTAL LITIGATION GROUP, Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No Inc., et al. P.C. Dismissal filed Remaining: Abbvie, Inc., Abbott Laboratories, Abbvie Products, LLC Prejudice objection objection Gary A. Anderson 12/16/2016 2160 Highland Ave. South, Suite 200 Birmingham, AL 35205 (205) 328‐9200 [email protected] William Casto and Sandy 1:16‐cv‐10398 Forman Law Offices, P.A. Theodore S. Stipulation of Entire action With No No Casto v. Eli Lilly and Forman Dismissal filed Dismissed: Eli Lilly and Company; Lilly USA, LLC; Acrux Commercial Pty Ltd; Acrux DDS Pty Prejudice objection objection Company, Lilly USA, LLC, 238 NE 1st Avenue 3/24/2017 Ltd Acrux Commercial Pty Delray Beach, FL 33444 (561) Ltd., Acrux DDS Pty Ltd., 266‐9998 [email protected] Campbell, Anton v. 1:15‐cv‐09352 Goldberg & Osborne Amended Complaint Dismissed: Actavis plc Without No No Actavis, Inc. David J. Diamond filed 1/5/16 Remaining: Actavis Inc. Prejudice Objection objection Daniel Gregory Sakall 698 E. Wetmore Road,Suite 200 Tucson, AZ 85705 Phone (520) 620‐3975 [email protected] [email protected]

Christopher Coyle v. 1:15‐cv‐08564 GORI JULIAN & ASSOCIATES, P.C. Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No AbbVie Inc., et al. D. Todd Mathews Dismissal filed 6/8/17 Inc. Prejudice objection objection 156 North Main Street Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Edwardsville, IL 62025 Pharmaceuticals LLC, Besins Healthcare Inc., Besins Healthcare SA Phone: (618) 659‐9833 Previously dismissed: Solvay, S.A.; Actavis plc and Watson Laboratories, Inc. Email: [email protected]

Page 6 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 8 of 36 PageID #:52873

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Bettyjane Flores, et al. v. 1:15‐cv‐04018 HARRIS LOWRY MANTON LLP Stephen Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No AbbVie Inc., et al. G. Lowry Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection Jed D. Manton 1/30/2017 Pharmaceuticals LLC, Besins Healthcare Inc., Besins Healthcare SA Madeline E. McNeeley Previously dismissed: Solvay, S.A. Kristy S. Davies 1201 Peachtree Street NE, Suite 900 Atlanta, GA 30361 (404) 961‐7650 Stanley B. Latty and 1:15‐cv‐11875 HARRIS LOWRY MANTON LLP Stephen Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No Donna B. Latty v. AbbVie, G. Lowry Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Actavis Inc., Actavis Prejudice objection objection Inc., et al. Jed D. Manton 1/30/2017 Pharma Inc., Actavis Laboratories UT, Inc., Anda, Inc., Auxilium Pharmaceuticals, Inc., Madeline E. McNeeley Besins Healthcare Inc., Besins Helathcare SA, Endo Pharmaceuticals Inc., Unimed Kristy S. Davies Pharameutials LLC 1201 Peachtree Street NE, Suite 900 Atlanta, GA 30361 (404) 961‐7650 Troy Cunningham v. 1:16‐cv‐00817 Heard Robins Cloud LLP Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Pharma, Inc., Actavis Without No No AbbVie Inc., et al. Bill Robins III Dismissal filed 12/2/16 Laboratories UT, Inc.; and Anda, Inc. Prejudice objection objection 808 Wilshire Blvd, Suite 450 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Santa Monica, CA 90401 Pharmaceuticals LLC, Besins Healthcare Inc, Besins Healthcare SA (310) 929‐4200 Previously dismissed: Solvay SA [email protected] Richardson, John v. 1:16‐cv‐05018 Heard Robins Cloud LLP Voluntary/Stipulated Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Without No No AbbVie Inc. et al. Bill Robins III Dismissal filed Pharmaceuticals, LLC, Besins Healthcare Inc. and Besins Healthcare, S.A. Prejudice objection objection 808 Wilshire Blvd, Suite 450 12/12/2016 Remaining: Eli Lilly and Company, Lilly USA LLC, Acrux Commercial Pty Ltd., Acrux DDS Santa Monica, CA 90401 Pty Ltd. and Solvay SA (310) 929‐4200 [email protected] Andrew D. Kennedy, et al. 1:15‐cv‐08176 HOVDE DASSOW & DEETS, LLC Stipulation of Dismissed: Actavis plc; Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Pharma, Inc.; Without No No v. AbbVie Inc., et al. Robert T. Dassow Voluntary Dismissal Actavis Laboratories UT, Inc.; Watson Laboratories Inc., a Nevada corporation Prejudice objection objection 201 W. 103rd Street, Suite 500 filed 10/3/16 Remaining: AbbVie Inc., Endo Pharmaceuticals Inc., Auxilium Pharmaceuticals Inc Indianapolis, IN 46290 Phone: (317) 818‐3100 Email: [email protected]

Page 7 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 9 of 36 PageID #:52874

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Fulbright v. Endo 1:16‐cv‐06756 Jackson Allen & Williams, LLP Stipulation for Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux With No No Pharmaceuticals, Inc. et al Jennifer Williams Voluntary Dismissal DDS Pty Ltd. Prejudice objection objection 3838 Oak Lawn Ave., Ste. 1100 9/28/16 Remaining: Endo Pharmaceuticals, Inc., Auxiulium Pharmaceuticals, Inc, GlaxoSmith Dallas, TX 75219 Kline LLC [email protected] Martone, Robert v. 1:17‐cv‐2475 Jackson Allen & Williams, LLP NOTICE of Voluntary Dismissed: Solvay, S.A. Without No No AbbVie Inc., et al. Jennifer Williams Dismissal filed Remaining: AbbVie Inc.; AbbVie Products LLC; Unimed Pharmaceuticals, LLC: Besins Prejudice Objection objection 3838 Oak Lawn Ave., Ste. 1100 4/13/2017 Healthcare, Inc.; Besins Healthcare, S.A. Dallas, TX 75219 [email protected] Glenn Hensley v. AbbVie 1:15‐cv‐04475 Jensen & Associates Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux With No No Inc.; et al. Brandon H. Steffey Dismissal filed DDS Pty Ltd. Prejudice Objection objection 1024 North Main St. 4/3/2017 Remaining: AbbVie Inc., Abbott Laboratories; AbbVie Products LLC Fort Worth, Texas 76164 (817) 334‐0762 [email protected] Muchoki, Charles v. 1:16‐cv‐10276 Kabateck Brown Kellner Stipulation of Dismissed: Solvay, S.A. Without No No AbbVie Inc. et al. Natalie S. Pang Dismissal without Remaining: AbbVie Inc.; AbbVie Products LLC; Unimed Pharmaceuticals, LLC: Besins Prejudice objection objection 644 S. Figueroa St. Prejudice on 12/7/16 Healthcare, Inc.; Besins Healthcare, S.A. Los Angeles, CA 90017 213‐217‐5000 [email protected] Martinez, Edwardo v. 1:16‐cv‐10290 Kabateck Brown Kellner Stipulation of Dismissed: Solvay, S.A. Without No No AbbVie Inc. et al. Natalie S. Pang Dismissal without Remaining: AbbVie Inc.; AbbVie Products LLC; Unimed Pharmaceuticals, LLC: Besins Prejudice objection objection 644 S. Figueroa St. Prejudice on 12/7/16 Healthcare, Inc.; Besins Healthcare, S.A. Los Angeles, CA 90017 213‐217‐5000 [email protected] Jose A. Fernandez, et al. 1:15‐cv‐05773 Kaiser Gornick LLP Amended complaint Dismissed: Watson Laboratories, Inc., a Nevada corporation Without No No v. AbbVie Inc., et al. David Markevitch filed 9/2/16 Remaining: AbbVie Inc., Abbott Laboratories, Actavis Inc., Actavis Pharma Inc., Anda, Prejudice Objection objection 950 Tower Lane, Suite 925 Inc., Actavis Laboratories UT, Inc. Foster City, CA 94404 (415) 857‐7400 [email protected]

Page 8 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 10 of 36 PageID #:52875

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute William E. Scott v. AbbVie 1:15‐cv‐01033 Kaiser Gornick LLP Amended complaint Dismissed: Watson Laboratories, Inc., a Nevada corporation Without No No Inc., et al. David Markevitch filed 9/2/16 Remaining: AbbVie Inc., Abbott Laboratories, Actavis Inc., Actavis Pharma Inc., Anda, Prejudice Objection objection 950 Tower Lane, Suite 925 Inc., Actavis Laboratories UT, Inc. Foster City, CA 94404 (415) 857‐7400 [email protected] Daniel Tambourine v. 1:15‐cv‐05838 Kaiser Gornick LLP Amended complaint Dismissed: Watson Laboratories, Inc., a Nevada corporation Without No No Actavis, Inc., et al. David Markevitch filed 9/2/16 Remaining: Actavis Inc., Actavis Pharma Inc., Anda, Inc., Endo Pharmaceuticals Inc., Prejudice Objection objection 950 Tower Lane, Suite 925 Actavis Laboratories UT, Inc. Foster City, CA 94404 (415) 857‐7400 [email protected] Mark Odom v. AbbVie, 1:15‐cv‐11475 Langdon & Emison Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No Inc., et al. Brett A. Emison Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Prejudice objection objection 911 Main Street 1/18/2017 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Endo P.O. Box 220 Pharmaceuticals, Inc. Lexington MO 64067 Previously dismissed: Solvay SA Telephone: 660‐259‐6175 [email protected] Patten v. AbbVie, Inc., et 1:16‐cv‐01180 LEVIN SIMES LLP Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No al. Rachel Abrams Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, Auxilium Pharmaceuticals Inc. Prejudice objection objection 44 Montgomery Street, 32nd Floor 01/06/2017 San Francisco, CA 94104 (415) 426‐3000 [email protected] Leon Ehlers v. Endo 1:15‐cv‐04830 LEVIN SIMES LLP Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC) Without No No Pharmaceuticals, Inc., et Rachel Abrams Dismissal 4/10/2017 Remaining: Endo Pharmaceuticals Inc. Prejudice objection objection al. 44 Montgomery Street, 32nd Floor San Francisco, CA 94104 (415) 426‐3000 [email protected]

Page 9 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 11 of 36 PageID #:52876

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Smith et al v. Auxilium 1:15‐cv‐08599 LEVIN SIMES LLP Stipulation of Dismissed: Auxilium Pharmaceuticals, Inc. With No No Pharmaceuticals, Inc. Rachel Beth Abrams Voluntary Dismissal Remaining: AbbVie Inc. and Abbott Laboratories Prejudice objection objection 44 Montgomery Street 32nd Floor filed 11/28/16 San Francisco, CA 94104 415‐426‐3001 [email protected] William J. Broussard, Sr., 1:15‐cv‐01006 LEVIN SIMES LLP Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC) Without No No et al. v. AbbVie Inc., et al. Rachel Beth Abrams Dismissal filed 3/15/17 Remaining: AbbVie Inc. and Abbott Laboratories Prejudice objection objection 44 Montgomery Street 32nd Floor San Francisco, CA 94104 415‐426‐3001 [email protected] Terry, Myles A. v. Pfizer, 1:16‐cv‐11268 Levin Simes LLP Notice of Voluntary Dismissed: Eli Lilly and Company With No No Inc. Rachel Beth Abrams Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories; Endo Pharmaceuticals, Inc.; Auxilium Prejudice Objection objection 44 Montgomery Street 32nd Floor 3/3/2017 Pharmaceuticals, Inc.; Actavis, Inc. San Francisco, CA 94101 Previously dismissed: Pfizer, Inc.; Pharmacia & Upjohn Co. Inc. Jeffery McKenzie v. 1:15‐cv‐03060 Levin Simes LLP Stipulation of Entire Action With No No Actavis, Inc., et al Rachel Beth Abrams Dismissal filed Dismissed: Actavis, Inc. Prejudice objection objection 44 Montgomery Street 32nd Floor 6/7/2017 San Francisco, CA 94101 Previously Dismissed: Pfizer Inc. and Pharmacia & Upjohn Co.

Greeno, Aubry S v. 1:15‐cv‐09856 Levin, Papantonio, Thomas, Mitchell, Voluntary/Stipulated Dismissed: AbbVie Inc. and Abbott Laboratories, Inc., AbbVie Products LLC and Unimed Without No No AbbVie Inc. et al. Rafferty & Proctor, PA Dismissal filed Pharmaceuticals LLC, Besins Healthcare Inc. and Besins Healthcare, S.A. ‐ DUPLICATE Prejudice Objection objection Brandon L. Bogle 9/30/2016 ACTION 316 S. Baylen Street, Suite 600 and 8/11/2017 Previously dismissed: Solvay, S.A. Pensacola, FL 32502 (850) 435‐7000 [email protected] Yvette Skaggs, Individually 1:14‐cv‐10075 LOCKRIDGE GRINDAL NAUEN PLLP Stipulation of Entire Action Without No No and as Wife of Yvonne M. Flaherty Voluntary Dismissal Dismissed: Eli Lilly and Company; Lilly USA, LLC Prejudice objection objection Decendent, Kevin Cribb v. 100 Washington Ave S, Suite 2200 filed 7/19/17 Eli Lilly and Company Minneapolis, MN 55401 (612) 339‐6900 [email protected]

Page 10 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 12 of 36 PageID #:52877

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Ringstaff v. AbbVie Inc., et 1:15‐cv‐05390 LOCKRIDGE GRINDAL NAUEN PLLP Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No al. Yvonne M. Flaherty Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection 100 Washington Ave S, Suite 2200 01/09/2017 Pharmaceuticals LLC, Solvay SA, Besins Healthcare Inc., Besins Healthcare SA, Endo Minneapolis, MN 55401 Pharmaceuticals, Auxilium Pharmaceuticals Inc, GlaxoSmithKline LLC (612) 339‐6900 Previously dismissed: Actavis plc, Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories [email protected] UT, Inc., Anda, Inc., Watson Laboratories, Inc., a Nevada corporation, Eli Lilly and Co., Lilly USA, LLC, Acrux Commercial Pty Ltd., and Acrux DDS Pty Ltd. Jacob A. Flint FLINT LAW FIRM 112 Magnolia Dr. P.O. Box 930 Glen Carbon, IL 62034 (618) 205‐2017 [email protected] Lee Lanclos v. Endo 1:15‐cv‐01052 Matthews & Associates Stipulation of Dismissed: Eli Lilly and Company; Lilly USA, LLC., With No No Pharmaceuticals David Paul Matthews Dismissal 4/17/2017 Remaining: Endo Pharmaceuticals, Inc. Prejudice objection objection 2905 Sacket Street Houston, TX 7098 888‐520‐5202 Rauder, Ludwig v. Eli Lilly 1:15‐cv‐07562 Matthews & Associates Stipulation of Dismissed: Eli Lilly and Company; Lilly USA, LLC; Acrux Commercial Pty Ltd.; and Acrux With No No and Company David Paul Matthews Dismissal filed DDS Pty Ltd. Prejudice Objection objection 2905 Sacket Street 3/8/2017 Remaining: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; Anda, Inc.; Houston, TX 7098 MDL Dismissal Filed in Endo Pharmaceuticals, Inc.; and Auxilium Pharmaceuticals, Inc. 888‐520‐5202 favor of Pfizer Inc. and Previously Dismissed: Watson Laboratories, Inc., Pfizer, Inc. and Pharmacia & Upjohn Pharmacia & Upjohn Company, Inc. Co. William Darious Bowman 1:16‐cv‐01347 MATTHEWS & ASSOCIATES Stipulation of Entire Action Without No No v. Pfizer Inc., et al. David P. Matthews Dismissal filed 3/1/17 Prejudice objection objection Wendy Elsey Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, 2905 Sackett Street MDL Judgment Inc. Houston, TX 77098 Entered in favor of Previously Dismissed: Pfizer, Inc. and Pharmacia & Upjohn Company, Inc. Phone: (713) 222‐8080 Pfizer Inc. and Email: [email protected] Pharmacia & Upjohn Co.

Page 11 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 13 of 36 PageID #:52878

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Eddie Johnese v. AbbVie 1:14‐cv‐08660 MATTHEWS & ASSOCIATES Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLD and f/k/a Watson Pharmaceuticals, Without No No Inc., et al. David P. Matthews Dismissal filed 3/1/17 Inc.) Prejudice objection objection Wendy Elsey Remaining: AbbVie, Inc. and Abbott Laboratories, Inc. 2905 Sackett Street Houston, TX 77098 Phone: (713) 222‐8080 Email: [email protected]

Peter T. Gagnier v. Pfizer 1:16‐cv‐01349 MATTHEWS & ASSOCIATES Stipulation of Entire Action Without No No Inc., et al. David P. Matthews Dismissal filed 6/12/17 Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Prejudice objection objection Wendy Elsey Inc. 2905 Sackett Street Previously Dismissed: Pfizer, Inc. and Pharmacia & Upjohn Company, Inc. Houston, TX 77098 Phone: (713) 222‐8080 Email: [email protected] Jose Taylor v. Abbvie Inc.; 1:16‐cv‐00165 Meyers & Flowers, LLC Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC, Acrux Commerical Pty Ltd., and Acrux With No No Abbott Laboratories; Brian J. Perkins Dismissal filed on DDS PTY Ltd. Prejudice objection objection Unimed Pharmaceuticals 3 North Second St. Suite 300 4/20/17 Remaining: AbbVie Inc.; Abbot Laboratories; Unimed Pharmaceuticals, LLC Llc; Solvay, S.A.; Eli Lilly St. Charles, IL 60174 Previously Dismissed: Solvay, S.A. and Company; Lilly USA (630) 232‐6333 LLC; Acrux Commercial bjp@meyers‐flowers.com Pty Ltd; Acrux DDS Pty Ltd

Clifford Goodman v. 1:16‐cv‐00117 Meyers & Flowers, LLC Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No AbbVie Inc., et al. Brian J. Perkins Dismissal filed 6/23/17 Inc. Prejudice objection objection 3 North Second St. Suite 300 Remaining: AbbVie Inc. and Abbott Laboratories St. Charles, IL 60174 (630) 232‐6333 bjp@meyers‐flowers.com

Page 12 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 14 of 36 PageID #:52879

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Thomas, Guy v. AbbVie, 1:16‐cv‐00128 MEYERS & FLOWERS, LLC (replacing Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC, Acrux Commerical Pty Ltd., and Acrux With No No Inc. et al Branch Law Firm) Dismissal Filed on DDS PTY Ltd. Prejudice objection objection Brian J. Perkins 1/31/17 Remaining: AbbVie Inc. 3 North Second Street, Suite 300 Abbott Laboratories St. Charles, IL 60174 Unimed Pharmaceuticals, LLC; Phone: (630) 232‐6333 Endo Pharmaceuticals, Inc. Email: bjp@meyers‐flowers.com Auxilium Pharmaceuticals, Inc. GlaxoSmithKline, LLC Actavis, Inc. Actavis Pharma, Inc. Actavis Laboratories UT, Inc. Anda, Inc. Previously Dismissed: Solvay, S.A. Liberty et al v. Endo 1:15‐cv‐04646 Morgan & Morgan, PA Amended Complaint Dismissed: Pfizer, Inc. Without No No Pharmaceuticals, Inc. Frank M. Petosa filed 12/08/16 Remaining: Endo Pharmaceuticals Inc. Prejudice objection objection 600 N. Pine Island Road Suite 400 Plantation, FL 33324 James McDonald v. 1:16‐cv‐02431 Morgan & Morgan, PA Stipulation of Entire Action Without No No Actavis et al. Frank M Petosa Dismissal filed 4/21/17 Dismissed: Actavis Inc., Actavis Pharma Inc., Actavis Laboratories UT, Inc., Anda, Inc. Prejudice objection objection 600 N Pine Island Rd Suite 400 Plantation, FL 33324 954/318‐0268 [email protected] Darrell McNeil et al. v. 1:16‐cv‐01460 MORRIS LAW FIRM Amended complaint Dismissed: Watson Laboratories, a Nevada Corporation Without No No Actavis Laboratories UT, James A. Morris, Jr. filed 7/26/2016 Remaining: Actavis Laboratories UT, Inc. Prejudice objection objection Inc., 6310 San Vincente Blvd., Suite 360 Los Angeles, CA 90048 Phone: (323) 455‐4444 Email: [email protected]

Page 13 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 15 of 36 PageID #:52880

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Shirley Cruickshank as 1:17‐cv‐00971 Napoli Shkolnik PLLC Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux With No No Personal Representative Christopher R. LoPalo Dismissal filed 7/13/17 DDS Pty Ltd. Remaining: AbbVie Inc., Abbott Laboratories, Prejudice objection objection of the Estate of Emerson 400 Broadhollow Road, Suite 305, New AbbVie Products LLC Unimed Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Cruickshank and Shirley York, NY 11747 Healthcare, S.A.; Endo Pharmaceuticals, Inc., Auxiulium Pharmaceuticals, Inc, GlaxoSmith Cruickshank Individually (212) 397‐1000 Kline LLC, Actavis plc, Actavis, Inc., Actacis Pharma, Inc., Actavis Laboratories UT, Inc., v. AbbVie Inc., et al. [email protected] Anda, Inc.; Solvay; Watson Laboratories Inc. Previously dismissed: Pfizer, Inc.; Pharmacia & Upjohn Company Inc.

Clyde Dodson v. AbbVie 1:16‐cv‐05087 OLIVER LAW GROUP P.C. Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No Inc., et al. Alyson L. Oliver Dismissal filed 5/31/17 Inc. Prejudice objection objection 363 W. Big Beaver Road, Suite 200 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Troy, MI 48084 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Eli Lilly and Phone: (248) 327‐6556 Company; Lilly USA LLC; Accrux Commerical Party Ltd. and Acrux DDS Pty Ltd. Email: [email protected] Previously dismissed: Solvay, S.A.; Acrux Limited; Actavis plc, and Watson Laboratories, Inc. William E. Kelly, et al. v. 1:15‐cv‐05937 ONDER, SHELTON, O’LEARY & Stipulation of Entire action With No No Pfizer, Inc., et al. PETERSON, LLC Dismissal filed Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC (with prejudice); Actavis Prejudice objection objection Michael J. Quillin 12/22/2016 Inc. (n/k/a Allergan Finance, LLC), Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Without 110 East Lockwood Anda, Inc (without prejudice) Prejudice St. Louis, MO 63119 Previously dismissed: Watson Laboratories Inc (NV) and Actvis plc (314) 963‐9000 [email protected] Richard F. Schulte, et al. v. 1:14‐cv‐08962 ONDER, SHELTON, O’LEARY & Stipulation of Dismissed: Pfizer Inc. With No No AbbVie Inc., et al. PETERSON, LLC Dismissal filed Remaining: AbbVie Inc. and Abbott Laboratories Prejudice objection objection Michael J. Quillin 12/22/2016 110 East Lockwood St. Louis, MO 63119 (314) 963‐9000 [email protected]

Page 14 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 16 of 36 PageID #:52881

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Louis J. Thomas v. AbbVie 1:15‐cv‐00950 Onder, Shelton, O'leary & Peterson LLC Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC) Without No No Inc., et al. Gerard L. Guerra Dismissal filed 3/1/17 Remaining: AbbVie Inc., Abbott Laboratories Inc., Auxilium Pharmaceuticals Inc., Endo Prejudice objection objection 110 E. Lockwood Ave. Pharmaceuticals Inc. St. Louis, MO 63119 Previously dismissed: Pfizer Inc. and Pharmacia and Upjohn Company, Watson (314) 963‐9000 Laboratories Inc., Endo International plc [email protected]

Randolph Palmer and 1:16‐cv‐10123 Onder, Shelton, O'leary & Peterson LLC Stipulation of Dismissed: Eli Lilly and Company; Lilly USA, LLC; Acrux Commercial Pty Ltd; Acrux DDS Pty Without No No Dawn Palmer v. Abbvie Gerard L. Guerra Dismissal filed Ltd. Prejudice objection objection Inc., et al. 110 E. Lockwood Ave. 3/20/2017 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie St. Louis, MO 63119 Products LLC, Unimed Pharmaceuticals, (314) 963‐9000 LLC, Besins Healthcare Inc., Besins [email protected] Healthcare, S.A.

Daniel Schieber v. Abbvie 1:16‐cv‐06236 Onder, Shelton, O'Leary & Peterson LLC Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC, Acrux Commerical Pty Ltd., and Acrux Without No No Inc.; Abbott Laboratories; Gerard L. Guerra Dismissal filed 5/3/17 DDS PTY Ltd. Prejudice objection objection Abbvie Products LLC; James Onder Remaining: Abbvie Inc.; Abbott Laboratories; Abbvie Products LLC; Unimed Unimed Pharmaceuticals, 110 E. Lockwood Ave. Pharmaceuticals, LLC.; Besins Healthcare Inc.; Besins Healthcare, S.A. LLC.; Solvay, S.A.; Besins St. Louis, MO 63119 Previously dismissed: Solvay, S.A. Healthcare Inc.; Besins (314) 963‐9000 Healthcare, S.A.; Eli Lilly [email protected] And Company; Lilly USA, LLC; Acrux Commercial Pty Ltd; Acrux DDS Pty Ltd

Hall, Terry v. AbbVie Inc. 1:16‐cv‐06321 Onder, Shelton, O'leary & Peterson LLC Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC, Acrux Commerical Pty Ltd., and Acrux Without No No Gerardo L. Guerra Voluntary Dismissal DDS PTY Ltd. Prejudice objection objection 110 E. Lockwood Ave. filed 10/28/2016 Remaining: Abbvie Inc.; Abbott Laboratories; Abbvie Products LLC; Unimed St. Louis, MO 63119 Pharmaceuticals, LLC.; Besins Healthcare Inc.; Besins Healthcare, S.A.; Endo (314) 963‐9000 Pharmaceuticals, Inc.; Auxilium Pharmaceuticals, Inc.; GlaxoSmithKLine, LLC

Page 15 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 17 of 36 PageID #:52882

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Sampson v. Pfizer, Inc. et 1:15‐cv‐03879 Onder, Shelton, O'leary & Peterson LLC Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company Inc. With No No al Michael Joseph Quillin Dismissal filed Remaining: Auxilium Pharmaceuticals Inc. and GlaxoSmithKline LLC Prejudice objection objection 110 E. Lockwood Ave. 12/22/16 St. Louis, MO 63119

Michael Coursen, et al. v. 1:16‐cv‐02676 Onder, Shelton, O'leary & Peterson LLC Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No AbbVie Inc., et al. Gerardo L. Guerra Dismissal filed 7/13/17 Inc. Prejudice objection objection 110 E. Lockwood Ave. Remaining: AbbVie Inc; Abbott Laboratories; Abbvie Products LLC; Unimed St. Louis, MO 63119 Pharmaceuticals, LLC; Solvay, S.A.; Besins Healthcare Inc.; Besins Healthcare, S.A. (314) 963‐9000 Previously Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company, Inc. e‐mail: [email protected]

Burkhart v. AbbVie Inc. et 1:15‐cv‐07374 Parker Waichman Alonso LLP Stipulation of Dismissed: Pfizer, Inc., and Pharmacia & Upjohn Company Inc. With No No al Daniel Christopher Burke Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Prejudice objection objection 6 Harbor Park Drive 12/13/16 Pharmaceuticals, LLC; Besins Healthcare Inc. and Besins Healthcare, S.A. Port Washington, NY 11050 Previously Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Limited and Acrux DDS 516‐723‐5631 Pty Ltd., Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc, GlaxoSmith Kline LLC, [email protected] Actavis plc, Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Inc., Medisca, Inc., Professional Compounding Centers of America, Watson Laboratories, Inc. and Solvay, S.A. Mary Jane Coulliette, et 1:15‐cv‐10473 PARKER WAICHMAN LLP Stipulation of Dismissed: Pfizer, Inc., and Pharmacia & Upjohn Company Inc. With No No al. v. AbbVie Inc., et al. Michael S. Werner Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Prejudice objection objection 6 Harbor Park Drive 12/13/2016 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Port Washington, NY 11050 Previously Dismissed: Solvay, S.A. (516) 466‐6500 [email protected] Clayton Darr and 1:15‐cv‐10946 PARKER WAICHMAN LLP Stipulations of Dismissed: Pfizer, Inc., and Pharmacia & Upjohn Company Inc. With No No Margaret Darr v. AbbVie Michael S. Werner Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection Inc., et al. 6 Harbor Park Drive 01/29/2016 and Pharmaceuticals, LLC, Besins Healthcare Inc. and Besins Healthcare, S.A. Port Washington, NY 11050 12/13/2016 Previously Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and (516) 466‐6500 Acrux DDS Pty Ltd. and Solvay, S.A., Actavis plc, Actavis, Inc., Actavis Pharma, Inc., Actavis [email protected] Laboratories UT, Inc., Watson Laboratories, Inc., Anda, Inc.

Page 16 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 18 of 36 PageID #:52883

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Charles & Clare Banzhof v 1:14‐cv‐08908 Provost Umphrey Law Firm Stipulations of Dismissed: Actavis, Inc., Pfizer Inc. and Pharmacia & Upjohn Company LLC Without No No Auxilium Christopher Thomas Kirchmer Dismissal filed Remaining: Auxilium Pharmaceuticals Inc. Prejudice objection objection Pharmaceuticals, Inc., 490 Park Street 1/26/2017 and as to Actavis, Inc., Pfizer, Inc. P.O. Box 4905 5/26/2017 Actavis, and Pharmacia & Upjohn Beaumont, TX 77701 Inc.; With Company Prejudice Daniel J. Carr as to Pfizer Peiffer Rosca Wolf Inc. and 201 St. Charles. Ave., Suite 4610 Pharmacia New Orleans, LA 70170 & Upjohn [email protected] Company LLC

George Knaepple v. 1:16‐cv‐8487 Reyes Browne Reilley Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux With No No AbbVie Inc., Abbott Spencer P. Browne Dismissal with DDS Pty Ltd. Prejudice objection objection Laboratories, et al. 5950 Berkshire Lane, Ste 410 Prejudice on 10/5/16 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Dallas, TX 75225 MDL Judgment Pharmaceuticals, Besins Healthcare Inc., Besins Healthcare, S.A., Endo Pharmaceuticals, (214) 526‐7900 Entered Auxilium Pharmaceuticals, GlaxoSmithKline, LLC, Actavis, Inc., Actavis Pharma, Inc., [email protected] Actavis Laboratories UT, Inc., Anda, Inc. Previously dismissed: Pfizer, Inc., Pharmacia & Upjohn Company, and Solvay, S.A. Billy Connock v. AbbVie 1:16‐cv‐08501 Reyes Browne Reilley Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No Inc., et al. Spencer P. Browne Dismissal filed 6/5/17 Inc. Prejudice objection objection 5950 Berkshire Lane, Ste 410 Remaining: AbbVie Inc; Abbott Laboratories; Abbvie Products LLC; Unimed Dallas, TX 75225 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. (214) 526‐7900 Previously Dismissed: Solvay, S.A. [email protected] Kevin Cunningham v. 1:15‐cv‐00751 ROBINSON CALCAGNIE, INC. Stipulation of Dismissed: Actavis, Inc. (f/k/a Watson Pharmaceuticals, Inc.) Without No No AbbVie Inc., et al. Daniel S. Robinson Dismissal filed 4/21/17 Remaining: Abbvie Inc., Abbott Laboratories Prejudice objection objection 19 Corporate Plaza Drive Newport Beach, CA 92660 [email protected]

Page 17 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 19 of 36 PageID #:52884

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Bowell, Sr., et al. v. 1:16‐cv‐01863 Schachter, Hendy & Johnson, PSC Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC Without No No AbbVie, Inc., et al. Ronald E. Johnson, Jr. Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection Sarah N. Emery 12/14/2016 Pharmaceuticals LLC, Besins Healthcare Inc., Besins Healthcare SA 909 Wright’s Summit Parkway, Suite 210 Previously dismissed: Solvay SA Ft. Wright, KY 41011 (859) 578‐4444 [email protected] [email protected]

Claude Aldridge, Jr. v. 1:15‐cv‐03035 Simmons Hanly Conroy Stipulation of Dismissed: Endo Pharmaceuticals Inc., Auxilium Pharmaceuticals, Inc. (n/k/a Auxilium Without No No AbbVie Inc., et al. Trent Miracle Voluntary Dismissal Pharmaceuticals, LLC), Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Laboratories UT, Prejudice objection objection Brendan Smith filed 11/3/2016 Inc.; Actavis Pharma, Inc.; and Anda, Inc. One Court Street Remaining: Abbvie Inc.; Abbott Laboratories; Abbvie Products LLC; Unimed Alton, IL 62002 Pharmaceuticals, LLC.; Besins Healthcare Inc.; and Besins Healthcare, S.A. Phone: (618) 259‐2222 Previously dismised: Solvay, S.A., Actavis plc, and Watson Laboratories, Inc. Email: [email protected]

Burton et al v. Eli Lilly and 1:14‐cv‐08739 Simmons Hanly Conroy Stipulation of Dismissed: Eli Lilly and Company; Lilly USA, Inc. With No No Company et al Trent Miracle Dismissal Filed on Remaining: Auxilium Pharmaceuticals, Inc. Prejudice objection objection Brendan Smith 1/31/17 One Court Street Alton, IL 62002 Phone: (618) 259‐2222 Email: [email protected]

Campbell, Luther v. 1:15‐cv‐03054 Simmons Hanly Conroy Voluntary/Stipulated Dismissed: Abbvie, Inc., Abbott Laboratories, AbbVie Products, LLC, Unimed Without No No AbbVie Inc. et al. Trent Miracle Dismissal filed Pharmaceuticals, LLC, Solvay SA, Besins Healthcare Inc, and Besins Healthcare SA Prejudice objection objection Brendan Smith 1/25/2017 Remaining: Eli Lilly and Company, Lilly USA LLC, Acrux DDS PTY Ltd., and Acrux Limited One Court Street Previously dismissed: Pfizer Inc., and Pharmacia & Upjohn Company Alton, IL 62002 MDL Judgment Phone: (618) 259‐2222 Entered dismissing Email: [email protected] Pfizer and Upjohn 4/21/2017

Page 18 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 20 of 36 PageID #:52885

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Alice Smith, Individually & 1:14‐cv‐07340 Stueve Siegel Hanson LLP Amended Complaint Dismissed: Actavis plc Without No No as surviving spouse obo Todd E. Hilton filed 1/23/15 Remaining: Actavis Inc, Actavis Pharma, Inc., Watson Laboratories, Inc., Anda Inc., Does 1‐Prejudice objection objection Fred Smith, deceased 460 Nichols Road, Suite 200 50, and Watson Laboratories, Inc. (Del.) Kansas City, MO 64112 Previously dismissed: McKesson Corporation (816) 714‐7100 [email protected] Richard Neal v. Abbvie 1:16‐cv‐812 MEYERS & FLOWERS, LLC (replacing Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux With No No Inc.; Abbott Laboratories; Branch Law Firm) Dismissal filed 2/3/17 DDS Pty Ltd. Prejudice objection objection Unimed Pharmaceuticals, Brian J. Perkins Remaining: Abbvie Inc.; Abbott Laboratories; Unimed Pharmaceuticals, Llc. Llc.; Solvay, S.A.; Eli Lilly 3 North Second Street, Suite 300 Previously Dismissed: Solvay, S.A. and Company; Lilly USA, St. Charles, IL 60174 LLC; Acrux Commercial Phone: (630) 232‐6333 Pty Ltd; Acrux DDS Pty Ltd Email: bjp@meyers‐flowers.com

Brinson v. Pfizer, Inc., et 1:15‐cv‐01871 The Lanier Law Firm Stipulation of Dismissed: Pfizer, Inc.; Pharmacia & Upjohn Company, Inc. With No No al. Catherine Heacox Dismissal filed Remaining: Abbott Laboratories, Inc.; Abbvie, Inc.; Abbvie Products LLC Prejudice objection objection W. Mark Lanier 12/27/2016 126 E. 56th Street, 6th floor New York, NY 10022 (212) 421‐2800 [email protected] George Robert Oxsheer 1:14cv04556 The Lanier Law Firm Stipulation of Dismissed: Eli Lilly and Company; Lilly USA, LLC With No No Jr.; Virginia Lee Oxsheer v. Catherine Heacox Dismissal filed 1/26/17 Remaining: Abbvie Inc.; Abbott Laboratories; Auxillium Pharmaceuticals, Inc., Jane Doe Prejudice objection objection Abbott Laboratories Inc.; W. Mark Lanier Distributors (1‐50), John Doe Drug Company Defendants (1‐50), Jane Doe Drug AbbVie Inc.; Auxilium 126 E. 56th Street, 6th floor Distributor Defendants (1‐50), Jim Doe Doe Health Care Providers (1‐50) and Jill Doe (1‐ Pharmaceuticals Inc.; Eli New York, NY 10022 50) Lilly and Company; Lilly (212) 421‐2800 USA LLC [email protected]

Amerson et al v. Abbott 1:14‐cv‐04554 The Lanier Law Firm Stipulation of Dismissed: Pfizer, Inc. With No No Laboratories Inc. et al Lee Adam Cirsch Dismissal filed Remaining: Abbvie Inc.; Abbott Laboratories; Auxillium Pharmaceuticals, Inc., Jane Doe Prejudice objection objection 2049 Century Park East Suite 1940 12/27/16 Distributors (1‐50), John Doe Drug Company Defendants (1‐50), Jane Doe Drug Los Angeles, CA 90067 Distributor Defendants (1‐50), Jim Doe Doe Health Care Providers (1‐50) and Jill Doe (1‐ 310‐277‐5100 50)

Page 19 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 21 of 36 PageID #:52886

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Ronald Couwenhoven v. 1:14‐cv‐04525 The Lanier Law Firm Stipulation of Dismissed: Actavis, Inc. Without No No Abbott Laboratories, et al. Cahterine Heacox Dismissal filed on Remaining: Abbott Laboratories; Abbvie, Jane Doe Distributors (1‐50), John Doe Drug Prejudice objection objection 126 East 56th Street, 6th floor 1/23/17 Company Defendants (1‐50), Jane Doe Drug Distributor Defendants (1‐50), Jim Doe Doe New York, NY 10022 Health Care Providers (1‐50) and Jill Doe (1‐50) Phone: (212) 421‐2800 Email: [email protected]

Collins v. AbbVie Inc., et 1:17‐cv‐789 The Lanier Law Firm Stipulation of Dismissed: Solvay S.A. Without No No al. Catherine Heacox Dismissal filed Remaining: Abbvie Inc.; Abbott Laboratories; AbbVie Products LLC; Unimed Prejudice Objection objection 126 East 56th Street, 6th floor 3/13/2017 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. New York, NY 10022 Phone: (212) 421‐2800 Email: [email protected]

Ronald Finley v. Actavis, 1:15‐cv‐07576 THE LAWRENCE FIRM Stipulation of Entire Action Without No No Inc., et al. Jennifer Lee Lawrence Dismissal filed 7/20/17 Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Prejudice objection objection 606 Philadelphia Street Inc. Covington, KY 41011 Previously dismissed: Actavis plc and Watson Laboratories, Inc. Phone: (859) 578‐9130 Email: [email protected]

Rachel Moore, 1:15‐cv‐09907 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No individually and as Scott D. Levensten Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Prejudice objection objection administrator of the 1420 Walnut Street, Suite 1500 12/22/2016 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. estate of Dirk Harper v. Philadelphia, PA 19102 Previously Dismissed by Order: Solvay, S.A. AbbVie Inc., et al. (215) 545‐5600 [email protected] Parker, et al. v. Endo 1:16‐cv‐02597 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Pfizer, Inc., and Pharmacia & Upjohn Company Inc. With No No Pharmaceuticals, Inc., et Scott D. Levensten Dismissal filed Remaining: Endo Pharmaceuticals, Inc., Auxiulium Pharmaceuticals, Inc, GlaxoSmith Prejudice objection objection al. 1420 Walnut Street, Suite 1500 01/09/2017 Kline LLC, Philadelphia, PA 19102 (215) 545‐5600 [email protected]

Page 20 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 22 of 36 PageID #:52887

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Robin Overby, et al. v. 1:15‐cv‐09850 THE LEVENSTEN LAW FIRM, P.C. Scott Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No AbbVie Inc., et al. D. Levensten Dismissal filed Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Prejudice objection objection Michael W. Johnston 1/30/2017 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. 1420 Walnut Street, Suite 1500 Previously Dismissed by Order: Solvay, S.A. Philadelphia, PA 19102 (215) 545‐5600 [email protected] [email protected] Jeff Berry, et al. v. Eli Liily 1:15‐cv‐09902 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Without No No & Company, et al. Scott Levensten Voluntary Dismissal Inc. Prejudice objection objection 1420 Walnut Street, Suite 1500 filed on 9/19/16 Remaining: Endo Pharmaceuticals, Inc., Auxiulium Pharmaceuticals, Inc, GlaxoSmith Philadelphia, PA 19102 Kline LLC, Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux DDS Phone: (215) 545‐5600 Pty Ltd. [email protected] Previously Dismissed: Actavis Plc and Watson Laboratories, Inc., a Nevada corporation

Spencer Edwards, et al. v. 1:15‐cv‐06161 THE LEVENSTEN LAW FIRM, P.C. Stipulations of Dismissed: Auxiulium Pharmaceuticals, Inc, GlaxoSmith Kline LLC, Actavis, Inc., Actacis Without No No AbbVie Inc., et al. Scott Levensten Voluntary Dismissal Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Inc. Prejudice objection objection 1420 Walnut Street, Suite 1500 filed on 12/22/15 and Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Philadelphia, PA 19102 9/19/16 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Endo Phone: (215) 545‐5600 Pharmaceuticals, Inc., Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd [email protected] and Acrux DDS Pty Ltd. Previously Dismissed by Order: Solvay, S.A., Actavis plc and Watson Laboratories, Inc., a Nevada corporation

Kenneth Farquhar v. 1:16‐cv‐00587 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Actavis, Inc., Actacis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Without No No AbbVie Inc., et al. Scott Levensten Voluntary Dismissal Inc. Prejudice objection objection 1420 Walnut Street, Suite 1500 filed on 10/20/16 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Philadelphia, PA 19102 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Eli Lilly and Phone: (215) 545‐5600 Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux DDS Pty Ltd. [email protected] Previously Dismissed by Order: Solvay, S.A.

Page 21 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 23 of 36 PageID #:52888

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Julio Martinez v. AbbVie 1:15‐cv‐07959 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Actavis, Inc., Actacis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Without No No Inc., et al Scott Levensten Voluntary Dismissal Inc. Prejudice objection objection 1420 Walnut Street, Suite 1500 filed 10/7/16 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Philadelphia, PA 19102 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Phone: (215) 545‐5600 Previously Dismissed by Order: Actavis plc, Watson Laboratories, Inc., a Nevada [email protected] corporation and Solvay, S.A.

Martin Parker, et al. v. 1:15‐cv‐04208 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Actavis, Inc., Actavis Pharma, Inc. and Anda, Inc. Without No No AbbVie Inc., et al. Scott Levensten Voluntary Dismissal Remaining: AbbVie Inc., Abbott Laboratories Prejudice objection objection 1420 Walnut Street, Suite 1500 filed 10/7/16 Previsously Dissmissed by Order: Watson Laboratories, Inc., a Nevada corporation Philadelphia, PA 19102 Phone: (215) 545‐5600 [email protected]

John Sparacino, et al. v. 1:15‐cv‐09671 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc. and Anda, Without No No AbbVie Inc., et al. Scott Levensten Voluntary Dismissal Inc. Prejudice objection objection 1420 Walnut Street, Suite 1500 filed 10/7/16 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed Philadelphia, PA 19102 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. Phone: (215) 545‐5600 Previously Dismissed by Order: Actavis plc, Watson Laboratories, Inc., a Nevada [email protected] corporation and Solvay, S.A.

Debra Pruitt, individually 1:15‐cv‐11143 THE LEVENSTEN LAW FIRM, P.C. Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No & as Administrator of the Scott Levensten Dismissal filed 7/11/17 Inc. Prejudice objection objection Estate of Robert Stewart 1420 Walnut Street, Suite 1500 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC Unimed v. AbbVie Inc., et al. Philadelphia, PA 19102 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A Phone: (215) 545‐5600 Previously dismissed: Solvay, S.A. [email protected] Stewart Davis v. AbbVie 1:16‐cv‐03086 THE MULLIGAN LAW FIRM Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Pharma, Inc.; Actavis With No No Inc., et al. Charles G. Orr Dismissal filed 3/31/17 Laboratories UT, Inc.; and Anda, Inc. Prejudice objection objection 3710 Rawlins Street, Suite 901 Remaining: AbbVie Inc., Abbott Laboratories Dallas, TX 75219 Previously dismissed: Watson Laboratories Inc (NV) Phone: (214) 219‐9779 Email: [email protected]

Page 22 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 24 of 36 PageID #:52889

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Larry Calhoun, Jr. v. 1:16‐cv‐05331 THE ORLANDO FIRM, P.C. Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Pharma, Inc.; Actavis Without No No AbbVie Inc., et al. Roger W. Orlando Dismissal filed 2/23/17 Laboratories UT, Inc.; and Anda, Inc. Prejudice objection objection 315 West Ponce de Leon Ave, Suite 400 Remaining: AbbVie, Inc.; Abbott Laboratories, Inc.; AbbVie Products, LLC; Unimed Decatur, GA Pharmaceuticals, LLC; Besins Healthcare, Inc.; Besins Healthcare, S.A. Phone: (404) 373‐1800 Previously Dismissed: Solvay, S.A. Email: [email protected]

Liangos v. AbbVie, Inc., et 1:14‐cv‐03106 TORHOERMAN LAW LLC Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company LLC With No No al. Tor A. Hoerman Dismissal filed Remaining: AbbVie Inc; Abbott Laboratories; AbbVie Products LLC; Unimed Prejudice objection objection Chad A. Finley 01/09/2017 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A.; Eli Lilly and 101 W. Vandalia Street, Suite 350 Company; Lilly USA, LLC; Acrux Commercial Pty Ltd; Acrux DDS Pty Ltd; Endo Edwardsville, IL 62025 Pharmaceuticals, Inc; Auxilium Pharmaceuticals, Inc; GlaxoSmithKline, LLC; Actavis, Inc.; (618) 656‐4400 Actavis Pharma, Inc.; Actavis Laboratories UT, Inc; Anda, Inc. [email protected] Previously Dismissed: Actavis plc and Watson Laboratories, Inc., a Nevada Corporation; [email protected] Solvay, S.A.

Kevin W. King v. AbbVie 1:16‐cv‐02426 TORHOERMAN LAW LLC Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Pharma, Inc.; Actavis Without No No Inc., et al. Tor A. Hoerman Dismissal filed 1/27/17 Laboratories UT, Inc.; Anda, Inc. Prejudice objection objection Chad A. Finley Remaining: AbbVie Inc; Abbott Laboratories; AbbVie Products LLC; Unimed 101 W. Vandalia Street, Suite 350 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. Edwardsville, IL 62025 Previously Dismissed: Solvay, S.A. (618) 656‐4400 [email protected] [email protected]

Page 23 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 25 of 36 PageID #:52890

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute William Bowels v. Eli Lilly 1:17‐cv‐01453 Wagstaff & Cartmell Stipulation of Entire action Without No No and Company, Lilly USA, Thomas Cartmell Dismissal as to Eli Lilly Dismissed: Eli Lilly and Company; Lilly USA, Inc.; Acrux Commercial Pty Ltd.; Acrux DDS Prejudice objection objection LLC, Acrux Commercial Jeffrey M. Kuntz and Company, Lilly Pty Ltd Pty Ltd., Acrux DDS Pty David C. DeGreeff USA, LLC, Acrux Previously dismissed: Pfizer Inc. and Pharmacia and Upjohn Company Ltd., Pfizer, Inc., 4740 Grand Avenue, Suite 300 Commercial Pty Ltd., Pharmacia & Upjohn Kansas City, MO 64112 Acrux DDS Pty Ltd. On Company Inc. Telephone: 816‐701‐1100 4/21/2017 Fax: 816‐531‐2372 [email protected] MDL Judgment [email protected] Entered 6/23/2017 [email protected] dismissing Pfizer, Inc. and Pharmacia & Upjohn Company Inc. with prejudice William Woodhouse v. 1:15‐cv‐09982 WAGSTAFF & CARTMELL, LLP Stipulation of Dismissed: Actavis, Inc. (n/k/a Allergan Finance, LLC); Actavis Pharma, Inc.; Actavis Without No No AbbVie Inc., et al. David Conrad Degreeff Dismissal filed Laboratories UT, Inc.; and Anda, Inc. Prejudice objection objection 4740 Grand Ave, Suite 300 11/17/16 Remaining: AbbVie Inc., AbbVie Products LLC, Abbott Laboratories; Unimed Kansas City, MO 64112 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A. (816)701‐1100 Previously dismissed: Actavis, plc, Watson Laboratories, Inc., a Nevada corporation, [email protected] Solvay SA Whitehead et al v. AbbVie 1:15‐cv‐06549 WAGSTAFF & CARTMELL, LLP David Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company Inc. Without No No Inc et al Conrad Degreeff Dismissal filed Remaining: AbbVie Inc; Abbott Laboratories; AbbVie Products LLC; Unimed Prejudice objection objection 4740 Grand Ave, Suite 300, Kansas City, 12/07/16 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A., Solvay SA, Endo MO 64112 Pharmaceuticals, Auxilium Pharmaceuticals Inc. (816)701‐1100 [email protected] Rigney v. AbbVie Inc. et al 1:15‐cv‐10742 WAGSTAFF & CARTMELL, LLP David Stipulation of Dismissed: Pfizer Inc. and Pharmacia & Upjohn Company Inc. Without No No Conrad Degreeff Dismissal filed Remaining: AbbVie Inc; Abbott Laboratories; AbbVie Products LLC; Unimed Prejudice objection objection 4740 Grand Ave, Suite 300, Kansas City, 12/07/16 Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare, S.A., Endo MO 64112 Pharmaceuticals, GlaxoSmithKline LLC (816)701‐1100 Previously dismissed: Solvay SA [email protected]

Page 24 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 26 of 36 PageID #:52891

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Stuebner, Bryan v. AbbVie 1:16‐cv‐10287 WAGSTAFF & CARTMELL, LLP David Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux Without No No Inc., et al Conrad Degreeff Dismissal filed DDS Pty Ltd. Prejudice objection objection 4740 Grand Ave, Suite 300, Kansas City, 3/7/2017 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed MO 64112 Pharmaceuticals, LLC, Besins Healthcare Inc., Besins Healthcare, S.A., Endo (816)701‐1100 Pharmaceuticals, Inc., Auxilium [email protected] Pharmaceuticals, Inc., GlaxoSmithKline, LLC Kenneth Mark Henderson 1:15cv1565 Wendt Law Firm, P.C Samuel Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC Without No No v. AbbVie Inc.; Abbott M. Wendt . Dismissal filed 1/26/17 Remaining: AbbVie Inc., Abbott Laboratories Prejudice objection objection Laboratories Inc.; Eli Lilly 1100 Main Street, Suite 2610 & Co.; Lily USA, LLC Kansas City, MO 64105 816‐531‐4415 Fax: 816‐531‐2507 Email: [email protected] Wendt Goss

Juliana A. Bunting as 1:15‐cv‐09699 ZOLL & KRANZ, LLC Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; Actavis Laboratories UT, Inc.; and Anda, Without No No Personal Representative James G. O'Brien Dismissal filed 2/24/17 Inc. Prejudice Objection objection of the Estate of Kenneth 6620 W. Central Ave., Suite 100 Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed F. Bunting, et al. v. AbbVie Toledo, OH 43617 Pharmaceuticals LLC, Besins Healthcare SA, Besins Healthcare Inc. Inc., et al. Tel. (419) 841‐9623 Previously dismissed: Watson Laboratories Inc., Actavis plc, Solvay SA Fax (419) 841‐9719 Email [email protected] Willie Cooper v. Abbott 1:14‐cv‐09508 ZOLL & KRANZ, LLC Stipulation of Dismissed: Actavis, Inc.; Actavis Pharma, Inc.; and Watson Laboratories, Inc. Without No No Laboratories, et al. James G. O'Brien Dismissal filed 7/12/17 Remaining: Abbott Laboratories; AbbVie Inc.; and Auxilium Pharmaceuticals, Inc. Prejudice objection objection 6620 W. Central Ave., Suite 100 Toledo, OH 43617 Tel. (419) 841‐9623 Fax (419) 841‐9719 Email [email protected] Boyd, Elizabeth, and 1:14‐cv‐08627 ZOLL & KRANZ, LLC Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial Pty Ltd and Acrux Without No No Matter of the Estate of James G. O'Brien Dismissal filed DDS Pty Ltd. Prejudice Objection objection Steven Boyd v. Auxilium 6620 W. Central Ave., Suite 100 3/2/2017 Remaining: Endo Pharmaceuticals, Inc.; Auxilium Pharmaceuticals, Inc,; GlaxoSmith Pharmaceuticals, Inc. Toledo, OH 43617 MDL Judgement Kline, LLC Tel. (419) 841‐9623 Entered 4/21/2017 as Previously Dismissed: Pfizer Inc. and Pharmacia & Upjohn Co. Fax (419) 841‐9719 to Pfizer and Email [email protected] Pharmacia & Upjohn

Page 25 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 27 of 36 PageID #:52892

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Coto et al v. Endo 1:15‐cv‐08584 Bernstein Liebhard LLP Stipulation of Dimissed: Eli Lilly and Company, Lilly USA, LLC, Acrux Commercial Pty Ltd. and Acrux DDS Without No No Pharmaceuticals, Inc. et al Daniel Christopher Burke Dismissal filed PTY Ltd. Prejudice Objection objection 10 East 40th Street, 28th Floor 5/24/2017 Remaining: Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc., GlaxoSmithKline, New York, NY 10016 LLC 212‐779‐1414 Fax: 212‐779‐3218 Email: [email protected] Mervyn D. Wisner v. Endo 1:16‐cv‐01195 Brandon H. Steffey JENSEN & Stipulation of Dismissed: Auxilium Without No No Pharmaceuticals, Inc. et al ASSOCIATES 1024 North Main Street Dismissal filed Pharmaceuticals, Inc., and GlaxoSmithKline, LLC Prejudice objection objection Fort Worth, TX 76164 Phone: (817) 334‐ 7/17/2017 Remaining: Endo Pharmaceuticals, Inc. 0762 Email: [email protected]

David Williams v. Endo 1:15‐cv‐00695 Meghan C. Quinlivan BURG SIMPSON Stipulation of Entire Action With No No Pharmaceuticals, Inc ELDREDGE HERSH JARDINE PC 40 Dismissal filed Dismissed: Endo Pharmaceuticals Inc. Prejudice objection objection Inverness Drive East Englewood, CO 6/29/2017 Previously Dismissed: PROSTRAKAN GROUP PLC 80112 (303) 792‐5595 (303) 708‐0527 FAX Email: [email protected] Ingersoll v. AbbVie, Inc. et 1:15‐cv‐02139 Bottar, Leone Law Firm Stipulation of Dismissed: Actient Pharmaceuticals, LLC; Slate Pharmaceuticals, Inc. Without No No al Michael A. Bottar 120 Dismissal filed Prejudice Objection objection Madison Street Suite 1600 AXA Tower 5/10/2017 Remaining: AbbVie Inc, Abbott Laboratories Inc., and Auxillium Pharmaceuticals Inc. II 16th Floor Syracuse, NY 13202 [email protected] John Taylor v. Abbvie, Inc. 1:14‐cv‐05030 Levin Simes LLP Stipulation of Entire Action With No No et al Rachel Beth Abrams Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories Prejudice objection objection 44 Montgomery Street 32nd Floor 6/6/2017 San Francisco, CA 94101 Moree v. AbbVie Inc. et al 1:16‐cv‐00001 MATTHEWS & ASSOCIATES Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC; Acrux Commercial PTY LTD.; and Acrux With No No David P. Matthews Dismsisal filed DDS PTY LTD. Prejudice Objection objection Wendy Elsey 5/10/2017 2905 Sackett Street Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Houston, TX 77098 Pharmaceuticals, LLC, Besins Healthcare Inc., Besins Healthcare, S.A., Endo Phone: (713) 222‐8080 Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc., Actavis, Inc., Actavis Pharma, Inc., Email: [email protected] Actavis Laboratories UT, Inc., Anda, Inc.

Page 26 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 28 of 36 PageID #:52893

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Lake v. Endo 1:16‐cv‐ 7396 Brian John Perkins Stipulation of Dismissed: Auxilium Pharmaceuticals, Inc. With No No Pharmaceuticals Inc. et al MEYERS & FLOWERS, LLC Dismsisal filed Prejudice Objection objection 3 North Second Street, Suite 300 7/24/2017 Remaining: Endo Pharmaceuticals Inc. Phone: (630) 232‐6333 Email: bjp@meyers‐flowers.com Burruss, Gary v. AbbVie 1:17‐cv‐02085 Johnson Becker, PLLC Voluntary/Stipulated Entire Action With No No Inc. et al. Timothy J. Becker Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection 33 South 6th Street, Suite 4530 6/9/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Minneapolis, MN 55402 Telephone: 612‐436‐1800 Fax: 612‐436‐1801 [email protected] Cisper, Jay v. AbbVie Inc. 1:16‐cv‐11744 ZOLL & KRANZ, LLC Voluntary/Stipulated Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Without No No et al. James G. O'Brien Dismissal filed Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Prejudice objection objection 6620 W. Central Ave., Suite 100 6/22/2017 Remaining: Eli Lilly and Company, Lilly USA, LLC, Acrux Commercial Pty Ltd. and Acrux Toledo, OH 43617 DDS PTY Ltd. Tel. (419) 841‐9623 Fax (419) 841‐9719 Email [email protected] Culver, Johnny v. AbbVie 1:17‐cv‐01335 Johnson Becker, PLLC Voluntary/Stipulated Entire Action With No No Inc. et al. Timothy J. Becker Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection 33 South 6th Street, Suite 4530 5/26/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Minneapolis, MN 55402 Telephone: 612‐436‐1800 Fax: 612‐436‐1801 [email protected] Flemmings, Marvin v. 1:17‐cv‐00920 Morgan & Morgan, PA Voluntary Dismissal Entire Action Without No No AbbVie Inc. et al. Frank M Petosa filed 7/12/2017 Dismissed: AbbVie Inc., Abbott Laboratories Prejudice objection objection 600 N Pine Island Rd Suite 400 Plantation, FL 33324 954/318‐0268 Email: [email protected]

Page 27 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 29 of 36 PageID #:52894

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Gilcrease, Kirk v. AbbVie 1:17‐cv‐02137 Peterson & Associates Voluntary/Stipulated Entire Action Without No No Inc. et al. David M. Peterson, Esq. Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection 801 W. 47th Street, Ste. 107 5/5/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Kansas City, MO 64112 Tel: (816) 531‐4440 [email protected] Gisbson, Ronald v. AbbVie 1:16‐cv‐01887 Discepolo LLP Voluntary/Stipulated Entire Action Without No No Inc. et al. A. Donald C. Discepolo Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Prejudice objection objection 8850 Columbia 100 Parkways 5/19/2017 Suite 310 Columbia, MD 21044 Telephone: 410‐296‐0780 [email protected] Martinez, Edward v. 1:16‐cv‐08497 Reyes Browne Reilley Voluntary/Stipulated Entire Action Without No No AbbVie Inc. et al. Spencer P. Browne Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection Berkshire Lane, Ste 410 3/14/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Dallas, TX 75225 Previously Dismissed: Solvay, S.A. (214) 526‐7900 [email protected] Polk, George v. AbbVie 1:16‐cv‐00263 MEYERS & FLOWERS, LLC (replacing Voluntary/Stipulated Entire Action With No No Inc. et al. Branch Law Firm) Dismissal filed Prejudice objection objection Brian J. Perkins 3/3/2017 Dismissed: AbbVie Inc., Abbott Laboratories, Unimed Pharmaceuticals, LLC and Solvay SA 3 North Second Street, Suite 300 St. Charles, IL 60174 Previously Dismissed: Solvay SA Phone: (630) 232‐6333 Email: bjp@meyers‐flowers.com Shiferaw, Yosef v. AbbVie 1:17‐cv‐01597 THE LEVENSTEN LAW FIRM, P.C. Voluntary/Stipulated Entire Action Without No No Inc. et al. Scott D. Levensten Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection 1420 Walnut Street, Suite 1500 7/5/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Philadelphia, PA 19102 215‐545‐5600 [email protected]

Page 28 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 30 of 36 PageID #:52895

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Stom, Ronald v. AbbVie 1:15‐cv‐09841 THE LEVENSTEN LAW FIRM, P.C. Voluntary/Stipulated Entire Action Without No No Inc. et al. Scott D. Levensten Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice objection objection 1420 Walnut Street, Suite 1500 5/15/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Philadelphia, PA 19102 Previously Dismissed: Solvay, S.A. 215‐545‐5600 [email protected] McDaniel, Charles v. 1:16‐cv‐10063 THE ORLANDO FIRM, P.C. Consent Motion and Entire Action ‐ DUPLICATE ACTION With No No AbbVie Inc. et al. Roger W. Orlando Agreement for Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 315 West Ponce de Leon Ave, Suite 400 Dismissal of Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Decatur, GA Defendants AbbVie Phone: (404) 373‐1800 Inc., et al. with Email: [email protected] prejudice filed 2/1/2017

Dillard, James v. AbbVie 1:17‐cv‐01622 Reyes Browne Reilley Voluntary/Stipulated Entire Action ‐ DUPLICATE ACTION Without No No Inc. et al. Spencer P. Browne Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 5950 Berkshire Lane, Ste 410 8/4/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Dallas, TX 75225 (214) 526‐7900 [email protected] Horton, John v. AbbVie 1:17‐cv‐01644 Reyes Browne Reilley Voluntary/Stipulated Entire Action ‐ DUPLICATE ACTION Without No No Inc. et al. Spencer P. Browne Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 5950 Berkshire Lane, Ste 410 8/4/2017 Pharmaceuticals, LLC, Besins Healthcare Inc., and Besins Healthcare, S.A. Dallas, TX 75225 (214) 526‐7900 [email protected] Jackson, Thomas v. 1:17‐cv‐00665 Douglas & London Voluntary/Stipulated Entire Action Without No No AbbVie Inc. et al. Michael A. London Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 59 Maiden Lane 6th Floor 8/4/2017 Pharmaceuticals, LLC New York, NY 10038 212‐931‐9979 [email protected]

Page 29 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 31 of 36 PageID #:52896

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Rogers, Robert v. AbbVie 1:17‐cv‐00425 Douglas & London Voluntary/Stipulated Entire Action ‐ DUPLICATE ACTION Without No No Inc. et al. Michael A. London Dismissal filed Dismissed: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 59 Maiden Lane 6th Floor 8/4/2017 Pharmaceuticals, LLC New York, NY 10038 212‐931‐9979 [email protected] Gary Acker v. AbbVie Inc. 1:17‐cv‐03816 Bahe Cook Cantley & Nefzger PLC Amended CMO 19B: Dismissed: Pfizer Inc.; Pharmacia & Upjohn Company, Inc. With No No et al. Sarah Beth Hackman Failure to serve Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 312 S 4th St., 6th Fl. response to Pfizer's Pharmaceuticals LLC, Besins Healthcare Inc. and Besins Healthcare S.A., Louisville, KY 40202 interrogatory and RFA 502‐587‐2002 within 30 days of filing [email protected] Short‐Form Complaint

Estes, Jeffrey v. AbbVie 1:17‐cv‐03898 Bahe Cook Cantley & Nefzger PLC Amended CMO 19B: Dismissed: Pfizer Inc.; Pharmacia & Upjohn Company, Inc. With No No Inc. et al. Sarah Beth Hackman Failure to serve Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Prejudice Objection objection 312 S 4th St., 6th Fl. response to Pfizer's Pharmaceuticals LLC, Besins Healthcare Inc., and Besins Healthcare S.A. Louisville, KY 40202 interrogatory and RFA 502‐587‐2002 within 30 days of filing [email protected] Short‐Form Complaint

Johnson, William Wade v. 1:17‐cv‐04587 Seithel Law, LLC Amended CMO 19B: Dismissed: Pfizer Inc.; Pharmacia & Upjohn Company, Inc.; Eli Lilly and Company, Lilly With No No AbbVie Inc. et al. Martha Lynn Seithel Failure to serve USA, LLC, Acrux Commercial Pty Ltd. and Acrux DDS PTY Ltd. Prejudice Objection objection Post Office Box 1929 response to Pfizer's Remaining: AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Charleston, SC 29457 interrogatory and RFA Pharmaceuticals LLC, Besins Healthcare Inc., and Besins Healthcare S.A., Endo (843) 557‐1699 within 30 days of filing Pharmaceuticals Inc., Auxilium Pharmaceuticals Inc., GlaxoSmithKline LLC, Actavis Inc., [email protected] Short‐Form Complaint; Actavis Pharma Inc., Actavis Laboratories UT, Inc. and Anda Inc., and John Doe Stipulation to Dismiss Defendants #1‐10 filed 07/31/17

Page 30 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 32 of 36 PageID #:52897

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Perry, Sr., Ronnie W. v. 1:17‐cv‐04798 Thomas & Wan, LLP Amended CMO 19B: Entire Action With No No Pfizer, Inc., Pharmacia Michelle Wymae Wan Failure to serve Dismissed: Pfizer Inc.; Pharmacia & Upjohn Company, Inc. Prejudice Objection objection and Upjohn Company, 1710 Sunset Blvd. response to Pfizer's Inc. Houston, TX 77005 interrogatory and RFA [email protected] within 30 days of filing Short‐Form Complaint

Atkins, Nelton v. AbbVie 1:17‐cv‐00462 Carey Danis & Lowe Amended CMO 19B: Dismissed: Pfizer Inc.; Pharmacia & Upjohn Company, Inc. With No No Inc. et al. James J Rosemergy Failure to serve Remaining: AbbVie, Inc. and AbbVie Products LLC Prejudice Objection objection 8235 Forsyth Blvd. response to Pfizer's Suite 1100 interrogatory and RFA St. Louis, MO 63105 within 30 days of filing [email protected] Short‐Form Complaint

Dillard Miracle v. Eli Lilly 1:16‐cv‐4727 ROBINSON CALCAGNIE, INC. Stipulation of Entire Action With No No and Company; Lilly USA, Daniel S. Robinson Dismissal of entire Dismissed: Eli Lilly and Company, Lilly USA, LLC, Acrux Commercial Pty Ltd., Acrux DDS Prejudice Objection objection LLC; Acrux Commercial 19 Corporate Plaza Drive action filed 5/8/17 Pty, Ltd. Pty Ltd; Acrux DDS Pty Ltd Newport Beach, CA 92660 [email protected]

Keith D. Jones v. Eli Lilly 1:15‐cv‐1680 Johnson Becker, PLLC Stipulation of Entire Action With No No and Compnay; Lilly USA, Timothy J. Becker, Esq. Dismissal filed 5/15/17 Dismissed: Eli Lilly & Co. and Lilly USA, LLC Prejudice Objection objection LLC 33 South 6th Street, Suite 4530 Minneapolis, MN 55402 Telephone: 612‐436‐1800 Fax: 612‐436‐1801 Email: [email protected]

Mark S. Harris and Elaine 1:14‐cv‐04261 Levin Fishbein Sedran & Berman Stipulation of Dismissed: Eli Lilly and Company, Lilly USA, LLC Without No No Harris v. AbbVie, Inc., Arnold Levin Dismissal filed 3/13/17 Remaining: AbbVie, Inc., Abbott Laboratories Prejudice Objection objection Abbott Laboratories, Inc., Michael M. Weinkowitz Lilly USA, Inc., and Eli Lilly 510 Walnut St., Suite 500 and Company Philadelphia, PA 19106 (215) 592‐1500 [email protected]

Page 31 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 33 of 36 PageID #:52898

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Joey Styles v. Lilly Usa Llc; 1:17‐cv‐3876 THE ORLANDO FIRM, P.C. Voluntary Dismissal Entire Action ‐ DUPLICATE With No No Eli Lilly & Company; Acrux Roger W. Orlando filed 6/8/17 Dismissed: Lilly Usa Llc; Eli Lilly & Company; Acrux Commercial Party Ltd.; Acrux Dds Pty Prejudice Objection objection Commercial Party Ltd.; 315 West Ponce de Leon Ave, Suite 400 Ltd Acrux Dds Pty Ltd Decatur, GA Phone: (404) 373‐1800 Email: [email protected]

Anthony Hansen v. 1:15‐cv‐4564 Fears | Nachawati Law Firm Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux With No No AbbVie Inc.; Abbott Matthew McCarley Dismissal filed 6/12/17 DDS Pty Ltd Prejudice Objection objection Laboratories; AbbVie 4925 Greenville Ave., Suite # 715 Remaining: AbbVie Inc.; Abbott Laboratories; AbbVie Products LLC; Unimed Products LLC; Unimed 214‐890‐0711 Pharmaceuticals LLC; Besins Healthcare Inc.; Besins Healthcare S.A. Previously Pharmaceuticals LLC; 214‐890‐0712 Dismissed: Solvay S.A. Solvay S.A.; Besins Healthcare Inc.; Besins Healthcare S.A.; Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux DDS Pty Ltd Cecil McCoy; Shelvy Jean 1:14‐cv‐9352 ENGLISH, LUCAS, PRIEST & OWSLEY, LLP Stipulation of Entire Action With No No McCoy v. Eli Lilly and Robert Young Dismissal filed 6/26/17 Dismissed: Eli Lilly and Company; Lilly USA, LLC Prejudice Objection objection Company; Lilly USA, LLC Lauren E. Marley Previously Dismissed: Pfizer Inc. and Pharmacia & Upjohn Co. 1101 College St. P.O. Box 770 Bowling Green, KY 42102 Telephone: 270‐781‐6500 Facsimile: 270‐782‐7782 [email protected]

Page 32 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 34 of 36 PageID #:52899

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Leonard Rideout and 1:15cv6104 Faraci Lange, LLP Stipulation of Entire Action With No No Theresa Rideout v. Eli Hadley L. Matarazzo Dismissal filed 6/21/17 Prejudice Objection objection Lilly and Company; Lilly 28 East Main Street, Suite 1100 Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux USA, LLC; Acrux Rochester, New York 14614 DDS Pty Ltd Commercial Pty Ltd.; (585) 325‐5150 Acrux DDS Pty Ltd. [email protected]

Debbie Watson for Silas 1:16cv1698 Carey, Danis & Lowe Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux With No No Watson v. Eli Lilly and James J. Rosemergy Dismissal filed 6/22/17 DDS Pty Ltd Prejudice Objection objection Company; Lilly USA, LLC; 8235 Forsyth Boulevard, Suite 1100, St. Remaining: AbbVie Inc.; Abbott Laboratories; AbbVie Products LLC; Unimed Acrux Commercial Pty Louis, MO 6310 Pharmaceuticals LLC; Besins Healthcare Inc.; Besins Healthcare S.A. Previously Ltd; Acrux DDS Pty Ltd; (314) 725‐7700 Dismissed: Solvay S.A. AbbVie Inc.; Abbott [email protected] Laboratories; Abbvie Products LLC; Unimed Pharmaceuticals LLC; Solvay, S.A.; Besins Healthcare Inc.; Besins Healthcare, S.A. James Jensen v. AbbVie 1:17cv1655 Reyes Browne Reilley Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux With No No Inc.; Abbott Laboratories; Spencer P. Browne 5950 Dismissal filed 7/17/17 DDS Pty Ltd Prejudice Objection objection AbbVie Products LLC; Berkshire Lane, Ste 410, Dallas, TX Remaining: AbbVie Inc.; Abbott Laboratories; AbbVie Products LLC; Unimed Unimed Pharmaceuticals 75225 (214) 526‐ Pharmaceuticals LLC; Besins Healthcare Inc.; Besins Healthcare S.A. LLC; Besins Healthcare 7900 Inc.; Besins Healthcare, [email protected] S.A.; Eli Lilly and Company; Lilly USA, LLC; Acrux Commercial Pty Ltd; Acrux DDS Pty Ltd

Page 33 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 35 of 36 PageID #:52900

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute Donald Ray Turner v. 1:16cv3259 Baird Brown Law Firm Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux Without No No Endo Pharmaceuticals, Baird A. Brown Dismissal filed 7/5/17 DDS Pty Ltd Prejudice Objection objection Inc., Auxilium 3055 Wilshire Blvd., Suite 1200, Los Remaining: Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc., Pharmaceuticals, Inc., Angeles, CA 90010 GlaxoSmithKline, LLC GlaxoSmithKline, LLC, Eli (213) 487‐ 8880 Lilly and Company, Lilly [email protected] USA, LLC, Acrux Commercial Pty Ltd, Acrux DDS Pty Ltd Johnny Hall v. Eli Lilly and 1:17cv1673 Reyes Browne Reilley Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux With No No Company; Lilly USA, LLC; Spencer P. Browne 5950 Dismissal filed 7/5/17 DDS Pty Ltd Prejudice Objection objection Acrux Commercial Pty Berkshire Lane, Ste 410, Dallas, TX Remaining: Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc., Ltd; Acrux DDS Pty Ltd; 75225 (214) 526‐ GlaxoSmithKline, LLC Endo Pharmaceuticals 7900 Inc.; Auxilium [email protected] Pharmaceuticals Inc.; Glaxosmithkline Llc

Thomas J. Mulholland v. 1:15cv10484 MATTHEWS & ASSOCIATES Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux With No No Eli Lilly and Company; Lilly David P. Matthews Dismissal filed 6/29/17 DDS Pty Ltd Prejudice Objection objection USA LLC; Acrux Wendy Elsey Remaining: Endo Pharmaceuticals Inc; Auxilium Pharmaceuticals Inc; Glaxosmith Kline Commercial Pty Ltd; 2905 Sackett Street LLC Acrux DDS Pty Ltd; Endo Houston, TX 77098 Previously Dismissed: Pfizer, Inc.; Pharmacia & Upjohn Company Inc. Pharmaceuticals Inc; Phone: (713) 222‐8080 Auxilium Pharmaceuticals Email: [email protected] Inc; Glaxosmith Kline LLC

Walter B. Harris v. Eli Lilly 1:16cv906 Brent Coon & Associates Stipulation of Entire Action Without No No and Company; Lilly USA, James A. Morris, Jr. Dismissal filed 7/5/17 Prejudice Objection objection LLC Robert A. Schwartz Dismissed: Eli Lilly and Company, Lilly Usa, Llc 300 Fannin, Suite 200 (713) 225‐1682 [email protected]

Page 34 of 35 Case: 1:14-cv-01748 Document #: 2105-1 Filed: 08/22/17 Page 36 of 36 PageID #:52901

In Re TRT Products Liab. Litig., MDL 2545, Agreed Dismissal List Per CMO 26 ‐ 8/22/2017

Case Name Case Number Plaintiff Counsel Basis for Dismissal Dismissed Parties/Claims/ Entire Action Type Defs.' Plaintiff's Dismissal Consent/ Consent/ Dispute Dispute William Mortimer v. Eli 1:16cv3254 Baird Brown Law Firm Stipulation of Entire Action Without No No Lilly and Company, Lilly Baird A. Brown Dismissal filed 7/5/17 Prejudice Objection objection USA, LLC, Acrux 3055 Wilshire Blvd., Suite 1200, Los Dismissed: Eli Lilly And Company, Lilly Usa, Llc Acrux Commercial Pty Ltd. And Acrux Dds Commercial Pty Ltd, Angeles, CA 90010 Pty Ltd. Acrux DDS Pty Ltd (213) 487‐ 8880 [email protected]

Michael Smith; Laura 1:15cv4905 Golomb & Honik, P.C. Stipulation of Dismissed: Eli Lilly and Company, Lilly, USA, LLC, Acrux Commercial Pty Ltd. and Acrux With No No Smith v. AbbVie Inc.; Steven Resnick Dismissal filed 7/24/17 DDS Pty Ltd Prejudice Objection objection Abbott Laboratories; Richard Golomb Remaining: AbbVie Inc.; Abbott Laboratories; AbbVie Products LLC; Unimed AbbVie Products LLC; 1515 Market Street, Suite 1100, Pharmaceuticals LLC; Solvay S.A.; Besins Healthcare Inc.; Besins Healthcare S.A. Unimed Pharmaceuticals Philadelphia, PA 19102 LLC; Solvay S.A.; Besins (215) 985‐9177 Previously Dismissed: Solvay S.A. Healthcare Inc.; Besins [email protected]; Healthcare S.A.; Eli Lilly [email protected] and Company; Lilly USA LLC.; Acrux Commercial Pty Ltd; Acrux DDS PTY Ltd.

Tyrone Borelli v. Eli Lilly 1:15cv3503 MATTHEWS & ASSOCIATES Stipulation of Entire Action With No No and Company; Lilly USA David P. Matthews Dismissal filed 8/4/17 Prejudice Objection objection LLC; Acrux Commercial Wendy Elsey Dismissed: Eli Lilly And Company, Lilly Usa, Llc Acrux Commercial Pty Ltd. And Acrux Dds Pty Ltd.; Acrux DDS pty 2905 Sackett Street Pty Ltd. Ltd. Houston, TX 77098 Previously Dismissed: Pfizer, Inc.; Pharmacia & Upjohn Company Inc.; Acrux Limited Phone: (713) 222‐8080 (terminated by ammended complaint 7/15/15) Email: [email protected]

Lodge, James v. AbbVie 1:17‐cv‐02395 Johnson Becker, PLLC Voluntary/Stipulation Entire Action – Dismissed AbbVie Inc. Abbott Laboratories, Inc. AbbVie Products, LLC, With No No Inc. et al. Timothy J. Becker, Esq. of Dismissal filed Unimed Pharmaceuticals, LLC, Besins Healthcare Inc. Besins Healthcare, S.A Prejudice objection objection 33 South 6th Street, Suite 4530 6/27/2017 Minneapolis, MN 55402 Telephone: 612‐436‐1800 Fax: 612‐436‐1801 Email: [email protected]

Page 35 of 35 Case: 1:14-cv-01748 Document #: 2105-2 Filed: 08/22/17 Page 1 of 5 PageID #:52902

Exhibit B Case: 1:14-cv-01748 Document #: 2105-2 Filed: 08/22/17 Page 2 of 5 PageID #:52903 In Re TRT Products Liability Litigation, MDL 2545-Motions to Dismiss with Prejudice Pursuant to Second Amended CMO 9 - 8/22/2017

CASE NAME CASE NUMBER MTD FILE PLAINTIFF COUNSEL DISMISSED TYPE STATUS DATE PARTIES/CLAIMS DISMISSAL John Hettish v. Actavis, Inc., 1:15-cv-11385 5/25/2017 Baron & Budd, P.C. Entire Action With Prejudice Response filed 6/7/17 et al. Matthew Haynie Dismissed: Oak Lawn Ave., Suite 1100 Actavis, Inc.; Dallas, TX 75219 Actavis Pharma, (214) 521-3605 Inc.; Anda, Inc.; [email protected] Actavis Laboratories UT, Inc. Kevin C. Lansdowne v. 1:16-cv-07827 5/23/2017 Beasley Allen Crow Methvin Portis Entire Action With Prejudice No Response AbbVie Inc., et al. & Miles, P.C. Dismissed: Matthew Patrick Teague AbbVie Inc.; 218 Commerce Street Abbott P.O. Box 1460 Laboratories; Montgomery, AL 36103 AbbVie Products (334) 269-2343 LLC; Unimed [email protected] Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare SA; Actavis, Inc.; Actavis Pharma, Inc.; Anda, Inc.; Actavis Laboratories UT, Inc.

Page 1 of 4 Case: 1:14-cv-01748 Document #: 2105-2 Filed: 08/22/17 Page 3 of 5 PageID #:52904 In Re TRT Products Liability Litigation, MDL 2545-Motions to Dismiss with Prejudice Pursuant to Second Amended CMO 9 - 8/22/2017

CASE NAME CASE NUMBER MTD FILE PLAINTIFF COUNSEL DISMISSED TYPE STATUS DATE PARTIES/CLAIMS DISMISSAL Arthur Chiappetta, et al. v. 1:16-cv-02759 7/3/2017 Morgan & Morgan, PA Entire Action With Prejudice No Response Actavis, Inc., et al. Frank M. Petosa Dismissed: 600 North Pine Island Rd.-Suite Actavis, Inc.; 400 Actavis Pharma, Plantation, FL 33324 Inc.; Anda, Inc.; (954) 318-0268 Actavis [email protected] Laboratories UT, Inc. Moore, Gregory v. AbbVie 1:16-cv-10074 5/23/2017 THE ORLANDO FIRM, P.C. Dismissed: With Prejudice No response Inc. et al. Roger W. Orlando AbbVie Products 315 West Ponce de Leon Ave, LLC, Abbott Suite 400 Laboratories Inc., Decatur, GA AbbVie Inc., Phone: (404) 373-1800 Unimed Email: [email protected] Phamaceuticals, LLC Remaining: Besins Healthcare Inc.; Besins Healthcare S.A.

Page 2 of 4 Case: 1:14-cv-01748 Document #: 2105-2 Filed: 08/22/17 Page 4 of 5 PageID #:52905 In Re TRT Products Liability Litigation, MDL 2545-Motions to Dismiss with Prejudice Pursuant to Second Amended CMO 9 - 8/22/2017

CASE NAME CASE NUMBER MTD FILE PLAINTIFF COUNSEL DISMISSED TYPE STATUS DATE PARTIES/CLAIMS DISMISSAL Wright, Calvin v. AbbVie Inc. 1:16-cv-10072 5/23/2017 THE ORLANDO FIRM, P.C. Dismissed: With Prejudice No response et al. Roger W. Orlando AbbVie Products 315 West Ponce de Leon Ave, LLC, Abbott Suite 400 Laboratories Inc., Decatur, GA AbbVie Inc., Phone: (404) 373-1800 Unimed Email: [email protected] Phamaceuticals, LLC Remaining: Besins Healthcare Inc.; Besins Healthcare S.A. Jones, Thomas v. AbbVie 1:16-cv-10375 5/23/2017 Provost Umphrey Law Firm Entire Action With Prejudice No response Inc. et al. Christopher Thomas Kirchmer Dismissed: 490 Park Street Abbott P.O. Box 4905 Laboratories Beaumont, TX 77701 Corporation, AbbVie Inc, AbbVie Products LLC

Page 3 of 4 Case: 1:14-cv-01748 Document #: 2105-2 Filed: 08/22/17 Page 5 of 5 PageID #:52906 In Re TRT Products Liability Litigation, MDL 2545-Motions to Dismiss with Prejudice Pursuant to Second Amended CMO 9 - 8/22/2017

CASE NAME CASE NUMBER MTD FILE PLAINTIFF COUNSEL DISMISSED TYPE STATUS DATE PARTIES/CLAIMS DISMISSAL Jennings, Ricky L. v. AbbVie 1:16-cv-10485 7/28/2017 Beasley, Allen, Crow, Methvin, Dismissed: With Prejudice No response Inc. et al. Portis & Miles, P.C. AbbVie Products Matthew P. Teague LLC, Abbott P O Box 4160 Laboratories Inc., Montgomery, AL 36103-4160 AbbVie Inc., Tel: 334-269-2343 Unimed Fax: 334-954-7555 Phamaceuticals, Email: LLC [email protected] Remaining: Besins Healthcare Inc.; Besins Healthcare S.A. Pridgeon, Brion v. AbbVie 1:16-cv-10987 7/28/2017 Douglas & London Entire Action With Prejudice Response filed 8/18/17 Inc. et al. Michael A. London Dismissed: 59 Maiden Lane 6th Floor Abbott New York, NY 10038 Laboratories, 212-931-9979 AbbVie Products [email protected] LLC, AbbVie Inc, Unimed Phamaceuticals, LLC

Page 4 of 4 Case: 1:14-cv-01748 Document #: 2105-3 Filed: 08/22/17 Page 1 of 4 PageID #:52907

Exhibit C Case: 1:14-cv-01748 Document #: 2105-3 Filed: 08/22/17 Page 2 of 4 PageID #:52908

Patterson Belknap Webb ~ Tyler LLP

1133 Avenue of the Americas New York, NY 10036-6710 212.336.2000 fax 212.336.2222 www.pbwt.com

June 15, 2017 William F. Cavanaugh, Jr. (212)336-2793 [email protected]

James R. Dugan II, Esq. The Dugan Law Firm, APLC 365 Canal Street, Suite 1000 New Orleans, Louisiana 70130

Re: Allied Services Division Welfare Fund a AbbVie Iizc., et a1., No. 15-cv-9525 (N.D. Ill.)

Dear James;

I write on behalf of AbbVie Inc., Abbott Laboratories, Abbott Products, Inc., Solvay America, Inc., Solvay Pharmaceuticals, Inc., Solvay S.A., and Unimed Pharmaceuticals, LLC (collectively, "AbbVie") concerning the Class Action Complaint ("Complaint") filed by Allied Services Division Welfare Fund ("Allied") on October 26, 2015. The Complaint was stayed "pending ruling on motions to dismiss" in Medical Mutual ofOhio v. AbbVie Inc., 14-cv-8857 (N.D. Ill.)(the "MMO Action"). See No. 15-9525, ECF No. 5 (N.D. Ill. Nov. 13, 2015). The last of those motions was decided over nine months ago, see 14-8857, ECF No. 170(N.D. Ill. Feb. 2, 2016), and Allied has taken no steps to pursue its claims since that time.

For the reasons below, we submit that the prudent course of action would be for Allied to dismiss its Complaint voluntarily. Indeed, Fed. R. Civ. P. 11 may require such action.

First, the Complaint plainly fails to state a claim under the Court's decisions to date. Those decisions apply equally to Allied's Complaint. For example:

• The Court has held that it lacks personal jurisdiction over Solvay S.A. and Solvay America, Inc. No. 14-8857, ECF No. 139 at 51-52(N.D. Ill. Feb. 5, 2016). The Complaint's claims against those entities are plainly subject to dismissal.

The Court has held that a TPP plaintiff may pursue state-law claims only under the laws of the state of its principal place of business. No. 14-8857, ECF No. 139 at 45-48. Allied has its "principal place of business ... [in] Illinois." (Compl. ¶ 9.) As such, the Complaint's claims that AbbVie violated the consumer- protection statutes of the 50 states (Counts V—VI) and the Louisiana Civil Code's provisions concerning redhibition (Count VII) are plainly subject to dismissal.

• The Court has held that RICO's proximate-cause requirement and Fed. R. Civ. P. 9(b), taken together, require a TPP to plead the time, place, and content of specific misrepresentations "made directly" to it by the defendant, which "induced the Case: 1:14-cv-01748 Document #: 2105-3 Filed: 08/22/17 Page 3 of 4 PageID #:52909

James R. Dugan II, Esq. June 15, 2017 Page 2

TPP to place the defendant's drug on formulary." No. 14-8857, ECF No. 139 at 36-41. Allied's Complaint falls far short of this standard: it contains no allegations whatsoever about communications made to it by any defendant—let alone particularized allegations about the time, place, or content of any misrepresentations that "induced [Allied] to place [AndroGel] on formulaxy."

Furthermore, based on the facts known to us, Allied could not amend its Complaint to cure any of these defects. In particular, with regard to the third defect, our investigation reflects that AbbVie never made direct representations to Allied. Moreover, Allied evidently had no formulary at all when AndroGel entered the U.S. market in 2000, and Allied evidently has not been involved in the design of its own formulary at any subsequent time. Allied Servs. Div. Welfare Fund v. GZaxoSmithKline, LLC, et al., No. 09-730, ECF No. 88-1 at 9(E.D. Pa. Aug. 29, 2016). Accordingly, Allied cannot possibly have made a decision to include AndroGel on its formulary in reliance on any false or misleading statements by AbbVie.

Second, AbbVie is aware that Allied is under threat of sanctions in the Avandia MDL for filing and pursuing similar RICO claims despite the lack of data to corroborate its allegations of injury and damages. No. 09-730, ECF No. 97(E.D. Pa. Nov. 8, 2016). From what AbbVie can tell, the evidentiary issues that eventually caused Allied to dismiss its own claims in the Avandia MDL (e.g., lack of prescription claims data for the time period at issue) would preclude Allied from proving its allegations in this case as well.

Finally, the Complaint is redundant. Allied is a member of the putative class in the MMO Action, and the damages it seeks on behalf of itself and other third-party payors are identical to those sought in the MMO Action. Allied's Complaint may be subject to dismissal for this reason alone. See, e.g., McReynolds v. Merrill Lynch & Co., 694 F.3d 873, 888-89(7th Cir. 2012)(affirming district court's dismissal of a "duplicative parallel action").

To the extent the Allied Complaint goes beyond the MMO Complaint by purporting to seek damages on behalf of"a class of consumers"(Compl. ¶ 2), that relief is unavailable as a matter of law. Allied is not a consumer, and no named plaintiff who is a consumer is identified in the Complaint. It is axiomatic that Allied "cannot represent a class to which [it] does] not belong." Rosario v. Rockefeller, 410 U.S. 752, 759 n.9 (1973). Additionally, because the interests of TPPs and consumers inherently diverge in a case of this nature, a single named plaintiff cannot possibly represent both types of entities consistent with Rule 23(a)(4)'s adequacy-of-representation requirement. See In re Synthroid Marketing Litig., 264 F.3d 712, 717 (7th Cir. 2001)("Had the TPPs held back and sued in subrogation, they might well have taken almost the entire fund [from the consumer plaintiffs]."). * * *

For the foregoing reasons, Allied should voluntarily dismiss its Complaint, as it did in the Avandia MDL. If Allied continues to do nothing, AbbVie will ask the Court to dismiss the Case: 1:14-cv-01748 Document #: 2105-3 Filed: 08/22/17 Page 4 of 4 PageID #:52910

James R. Dugan II, Esq. June 15, 2017 Page 3

Complaint for lack of prosecution. If Allied takes steps to prosecute this action without curing the defects in its Complaint (and, as explained above, AbbVie believes they cannot be cured), AbbVie will move to dismiss, and it may seek the costs associated with such a motion.

We would appreciate a response setting forth Allied's intended course of action no later than June 30, 2017.

Very truly yours,

~~~

William F. Cavanaugh, .Ir.

cc: Art Sadin, Esq. Jonah Knobler, Esq. Andrew Solow, Esq. Robert Grass, Esq. Ingo Sprie, Esq. Case: 1:14-cv-01748 Document #: 2105-4 Filed: 08/22/17 Page 1 of 2 PageID #:52911

Exhibit D Case: 1:14-cv-01748 Document #: 2105-4 Filed: 08/22/17 Page 2 of 2 PageID #:52912